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Abstract
Background: Thyroid hormones (THs) are vital in the maintenance of homeostasis and in the
control of development. One postembryonic developmental process that is principally regulated
by THs is amphibian metamorphosis. This process has been intensively studied at the genomic level
yet very little information at the proteomic level exists. In addition, there is increasing evidence that
changes in the phosphoproteome influence TH action.
Results: Here we identify components of the proteome and phosphoproteome in the tail fin that
changed within 48 h of exposure of premetamorphic Rana catesbeiana tadpoles to 10 nM 3,5,3'-
triiodothyronine (T3). To this end, we developed a cell and protein fractionation method combined
with two-dimensional gel electrophoresis and phosphoprotein-specific staining. Altered proteins
were identified using mass spectrometry (MS). We identified and cloned a novel Rana larval type I
keratin, RLK I, which  may be a target for caspase-mediated proteolysis upon exposure to T3. In
addition, the RLK I transcript is reduced during T3-induced and natural metamorphosis which is
consistent with a larval keratin. Furthermore, GILT, a protein involved in the immune system, is
changed in phosphorylation state which is linked to its activation. Using a complementary MS
technique for the analysis of differentially-expressed proteins, isobaric tags for relative and absolute
quantitation (iTRAQ) revealed 15 additional proteins whose levels were altered upon T3 treatment.
The success of identifying proteins whose levels changed upon T3 treatment with iTRAQ was
enhanced through de novo sequencing of MS data and homology database searching. These proteins
are involved in apoptosis, extracellular matrix structure, immune system, metabolism, mechanical
function, and oxygen transport.
Conclusion: We have demonstrated the ability to derive proteomics-based information from a
model species for postembryonic development for which no genome information is currently
available. The present study identifies proteins whose levels and/or phosphorylation states are
altered within 48 h of the induction of tadpole tail regression prior to overt remodeling of the tail.
In particular, we have identified a novel keratin that is a target for T3-mediated changes in the tail
that can serve as an indicator of early response to this hormone.
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Background
Thyroid hormones (TH) are important signaling mole-
cules in vertebrates that regulate homeostasis, growth, and
development. One developmental process that is depend-
ent upon the presence of TH is amphibian metamorpho-
sis. During metamorphosis the larval, aquatic,
herbivorous tadpole transforms into a terrestrial, carnivo-
rous juvenile frog. This event requires drastic changes in
essentially every organ and tissue of the tadpole and
includes: the resorption of larval organs and tissues,
remodeling of larval organs into juvenile form, and de
novo development of organs and tissues [1]. Metamorpho-
sis is completely controlled through the control of serum
TH levels. The thyroid gland mainly produces the thyroid
hormone, 3,5,3',5'-tetraiodothyronine (T4 or thyroxine),
which is converted into the biologically more active form,
3,5,3'-triiodothyronine (T3), in the peripheral tissues
[1,2]. Progression through natural metamorphosis is
dependent upon a tightly-controlled rise and fall in TH
levels. Premetamorphic tadpoles are functionally athyroid
with no measurable levels of THs [3]. TH levels gradually
increase during prometamorphosis and reach maximal
levels at metamorphic climax. At this stage, overt remod-
elling of the tadpole rapidly ensues. Premetamorphic tad-
poles can be induced to undergo precocious
metamorphosis by exposure to TH [1].
The best understood mechanism of TH action involves TH
binding to nuclear thyroid hormone receptors (TRs)
which regulate gene expression [2,4]. TH binding to TRs
can either activate or repress transcription of responsive
genes through recruitment of coactivators and corepres-
sors, respectively [2,4]. Differential nuclear TR levels and
intracellular T3 levels controlled by deiodinase activity
and TH-binding proteins, contribute to tissue-specific
responses [1,2,4]. However, the response to TH also
depends on the existing complement of other proteins
that can influence cell fate (e.g. regression of the tail versus
growth and differentiation of the hindlimb). However,
the molecular mechanisms are poorly understood.
Most TH-responsive genes are up-regulated and these
have been most commonly studied particularly in the tail
[5-10]. The genetic program required for tail regression is
established between 24 and 48 h of TH exposure at a
"commitment point" after which removal of TH or expo-
sure to transcription or protein synthesis inhibitors can-
not prevent regression [5,11]. Studies based on PCR
subtractive hybridization methods and cDNA gene arrays
have identified a number of possible genes involved in
this process [5-9]. However, the relationship of most of
these genomic findings to changes in the proteome has yet
to be identified and there is growing evidence for non-
classical TH action through phosphorylation signaling
pathways [12-16].
Proteomic scale studies on TH-dependent tail regression
have been scarce. Ray et al. identified several 35S-methio-
nine labelled proteins from Rana catesbeiana tail fin that
change during natural and precocious metamorphosis
using two-dimensional (2D) gel analysis [17]. Kobayashi
et al. used 2D gel electrophoresis to analyze changes in
protein expression in the back and tail skin of Xenopus lae-
vis during metamorphosis [18]. From the 2D protein spot
patterns they could classify the back skin into larval or
adult type and observe the transition. Attempts were made
in these studies to identify the altered protein spots. This,
however, involved identifying the spots based on posi-
tion, comigration or immunological detection methods.
Using 2D gel separation and mass spectrometry (MS) for
protein identification, we were able to identify 9 proteins
whose expression was altered in the X. laevis tadpole tail
during TH-induced metamorphosis [6]. Regardless of the
approach, the lack of any sample fractionation led to the
identification of only abundant proteins.
In this work we identified novel changes in the proteome
and phosphoproteome associated with the induction of
T3-dependent tail regression of Rana catesbeiana tadpoles.
Proteins that changed in abundance were detected using
two-dimensional (2D) gel electrophoresis and isobaric
tags for relative and absolute quantitation (iTRAQ) meth-
ods. Alterations in phosphorylation were revealed using a
phosphoprotein-specific stain. Mass spectrometry (MS)
analyses were then used for protein identification. Pro-
teome coverage was enhanced through the use of cell and
protein fractionation to reveal several proteins that are
altered within 48 h of T3 exposure.
Results and discussion
Fractionation of the tail fin proteome and 2D gel analyses
The subcellular fractionation method was optimized to
provide highly enriched fractions of cytosolic, mitochon-
drial, nuclear and microsomal samples from the R. cates-
beiana  tail fin. The goals of the method were to limit
sample complexity with effective cell fractionation with
minimal cross-contamination and reasonable yields. The
fractions also had to be salt and buffer-compatible with
subsequent proteomic analysis.
We developed two separate procedures based on differen-
tial centrifugation to generate nuclear and cytosolic/mito-
chondrial/microsomal fractions (Fig. 1A). The nuclear
extraction procedure was optimized to minimize nuclear
clumping, increase nuclei stability, and minimize
cytoskeletal, cytoplasmic/organelle and DNA contamina-
tion. The cytosolic/mitochondrial/microsomal extraction
procedure was developed to increase the disruption of tail
fin cell membrane and increase mitochondrial stability
and purity. The mitochondria-enriched fraction was
obtained with a 12,000 × g centrifugation and it likely alsoBMC Developmental Biology 2007, 7:94 http://www.biomedcentral.com/1471-213X/7/94
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contained lysosomes, peroxisomes, Golgi and endoplas-
mic reticulum (ER). Centrifugation at 100,000 × g
removed the vesicles of the plasma membrane, endo-
somes, Golgi and ER into the microsomal pellet leaving
the cytosolic supernatant with its soluble molecules
(cytosolic fraction; Fig. 1B). Nuclear integrity was moni-
tored by microscopy (data not shown) and fractionation
efficiency was determined using immunoblot analysis for
subcellular markers. An immunoblot for cytochrome c (a
mitochondrial marker) shows substantial enrichment for
that organelle in the mitochondrial fraction (Fig. 1C)
while an immunoblot for the nuclear markers, lamins B1
and B2, shows enrichment of nuclei in the nuclear frac-
tion (Fig. 1D).
The cytosolic fraction is a complex mixture of many pro-
teins and was therefore further fractionated using anion-
exchange high performance liquid chromatography
(HPLC) (Fig. 2A). A step-gradient anion-exchange HPLC
procedure was developed that used ammonium bicarbo-
nate as a volatile buffer in place of commonly used salt
and non-volatile buffer to provide salt-free fractions after
lyophilization to render the samples compatible with the
subsequent 2D gel analysis. The cytosolic fraction was
thus further fractionated into five fractions: 40 mM
(unbound proteins), 190 mM, 260 mM, 340 mM and 1 M
ammonium bicarbonate with each fraction (except 40
mM) yielding roughly equal amounts of protein as shown
by SDS-PAGE (Fig. 2B). Proteins within each of the result-
ing fractions were then separated by 2D polyacrylamide
gel electrophoresis which separates proteins based on
their molecular weight and isoelectric point (pI). There-
fore, the entire fractionation protocol divided the tail fin
proteome over eight 2D gels: nuclear, mitochondrial,
microsomal (Fig. 3) and five cytosolic fractions (Fig. 4).
This fractionation method increases the ability to observe
expression changes in low abundance proteins and pro-
vides information on subcellular localization of proteins
which cannot be achieved by examining a whole cell
homogenate on a single 2D gel. From our results, it is evi-
dent that each of the fractions shows a distinctive pattern
of spots with many unique spots per fraction analyzed
(Figs. 3 and 4). There is some overlap with the more abun-
dant protein spots between the neighboring fractions of
the HPLC separation and between the microsomal and
mitochondrial fractions, which probably share many cel-
lular membrane compartments (e.g. Golgi, ER, and lyso-
somes). Phosphoproteins were detected on the 2D gels
with a phosphoprotein-specific fluorescent stain (Pro-Q
Diamond) which detects phosphorylation on Ser, Thr and
Tyr residues [19] (Figs. 3 and 4). Total proteins and phos-
phoproteins were detected in the same 2D gel allowing for
easy identification of phosphoprotein location and subse-
quent isolation for MS analysis.
Subcellular fractionation of the tail fin proteome Figure 1
Subcellular fractionation of the tail fin proteome. (A) 
Fractionation of tail fin cells into subcellular compartments 
and subsequent treatments of those fractions. Two different 
extraction procedures, based on differential centrifugation, 
were developed to generate the nuclear and the cytoplasmic/
mitochondrial/microsomal fractions. (B) SDS-PAGE shows 
the successful fractionation of the total tail fin proteome into 
the cytosolic (Cytos), mitochondrial (Mito), microsomal 
(Micros), and nuclear (Nucl) fractions. Relative molecular 
weights of protein standards are indicated in kDa. (C) Immu-
noblot of the gel in (B) for the mitochondrial marker, cyto-
chrome c (arrow) showing the enrichment of mitochondria 
in the expected fraction. (D) Immunoblot of the gel in (B) for 
the nuclear markers, lamin B1 and B2 (double arrow) show-
ing the enrichment of nuclei in the expected fraction.
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The above methods were used to analyze the proteome
and phosphoproteome of the premetamorphic R. catesbe-
iana tail fin undergoing precocious metamorphosis at 24
and 48 h induced with 10 nM T3. A minimum of three
independent replicates allowed for the verification of
changes in protein and phosphoprotein expression and
MS analysis was used for protein identification.
Identification of a unique R. catesbeiana keratin fragment
A prominent protein spot at ~24 kDa and pI ~5 was
increased upon T3 treatment on the 2D gels of several frac-
tions (Fig. 5A). It was observed in the 340 mM cytoplas-
mic fraction as well as in the microsomal, mitochondrial
and nuclear fractions. This protein spot was increased by
2–3 fold as early as 24 h (data not shown), but was more
intensely expressed at 48 h (2.6 to 5.1 fold increase
depending on the fraction) (Fig. 5B). The greatest increase
was observed in the microsomal fraction. The protein
spots from each of the fractions were separately analyzed
by mass spectrometry proving that each fraction repre-
sented the same protein. A combination of electrospray-
ionization quadrupole time-of-flight (ESI-QqTOF) and
matrix-assisted laser desorption ionization TOF-TOF
(MALDI-TOF-TOF) tandem-MS (MS/MS) analyses
allowed for peptide sequence information to be obtained
for 11 different peptides from this protein (Table 1). Pro-
tein database searches with these peptides gave the high-
est homology match to the X. laevis type I keratin 47 kDa
protein [NCBI: P05781] also known as X. laevis keratin B2
[NCBI: 1304283B) from the XK81 gene family [20].
Parts of the amino acid sequence from two peptides
(ALEAANTELELK and NHEEELQVAR) flanking the
majority of the peptide sequence identified were used to
generate degenerate primers. Degeneracy was limited by
taking into account codon usage bias for R. catesbeiana
and other identified type I keratin cDNA sequences. Two
primers with 32 fold degeneracy each generated a single
380 bp PCR product from R. catesbeiana tail cDNA. Based
on this sequence two gene specific primers (GSP) were
designed to perform 5'- and 3'-rapid amplification of
cDNA ends (RACE). Two overlapping clones were
obtained from the 5'- and 3'-RACE containing the entire
open reading frame of this keratin gene (Fig. 6). The
cloned sequence was 1728 bp long, with a 109 bp 3'-
untranslated region, and a polyadenylation signal,
AATAAA, at 17 nucleotides upstream of the poly(A) tract.
The deduced amino acid sequence coded for a 481 amino
acid protein (predicted size of 52 kDa and pI 5.0) and
matched exactly all of the observed peptides from the MS
analysis indicating that the correct corresponding cDNA
sequence was cloned. BLASTp [21] analysis and ClustalW
[22] alignment with this 481 amino acid sequence
revealed the highest identity and similarity (80 and 90%,
respectively) with the X. laevis type I keratin 47 kDa pro-
tein [NCBI: P05781] (Fig. 7). About a dozen keratin pro-
teins have been identified for X. laevis [23,24]. In R.
catesbeiana only four keratin proteins have been defined
so far. These include the adult and larval keratins, RAK
and RLK, respectively, and a keratin K8 and inner-ear
cytokeratin [25,26]. RAK is the only acidic type I keratin
while the remaining three are basic-neutral type II kerat-
ins. The sequence we identified is 73% identical (84%
similar) to RAK [NCBI: BAB47394.1] and 32–33% identi-
cal to the type II keratins: RLK, Rana keratin K8 and inner-
ear cytokeratin (Fig. 7 and data not shown). Our sequence
also showed 67% identity (81% similarity) to the human
type I keratin 19 (K19) protein [NCBI: NP_002267.2].
Based upon this evidence and that presented below, the
isolated sequence constitutes a novel Rana type I keratin
which we will refer to as RLK I. The previous type II larval
RLK will be referred to as RLK II.
Keratins are expressed by epithelial cells where they
impart a mechanical function. In recent years, they have
also been shown to be posttranslationally modified dur-
ing cell stress, apoptosis, and cell signaling [27,28]. Kerat-
ins have been extensively studied in anurans during skin
differentiation and metamorphosis. The skin in R. catesbe-
iana transitions from a larval type into a pre-adult type,
and finally into an adult type with the onset of metamor-
phosis [25,26]. These changes are associated with the dif-
ferentiation and apoptosis of specific epidermal cells and
changes in connective tissue [25,29]. Each of these
changes have been associated with alterations in keratin
type expression in specific cells [23,30]. RLK II expression
was reduced in tadpole tail and body skin with the onset
of metamorphosis while RAK expression increased [30].
These changes are precociously induced by T3 and similar
changes have been observed in X. laevis with its corre-
sponding larval and adult keratin genes [23,24].
RLK I had the highest homology to the X. laevis type I ker-
atin 47 kDa which is expressed during embryonic and lar-
val stages, reduced during metamorphosis, and expressed
at very low levels in the adult skin [20]. In order to deter-
mine the transcript levels of RLK I, we performed quanti-
tative real-time polymerase chain reaction (QPCR)
analysis on tail samples from premetamorphic R. catesbe-
iana tadpoles exposed to T3 and during normal tadpole
development. Exposure of premetamorphic tadpoles to T3
significantly reduced the steady-state levels of the RLK I
transcript by 1.9 and 5.2 fold at 48 and 72 h, respectively,
relative to time-matched controls (Fig. 8A). The same
trend was observed during natural metamorphosis. The
steady-state level of the keratin transcript remained
unchanged from premetamorphosis [Taylor and Kollros
(TK) stage VI-VIII [31] ], through prometamorphosis (TK
stage XII-XIX) and then decreased by 3.1 fold upon reach-
ing metamorphic climax (TK stage XX-XXII) when TH lev-BMC Developmental Biology 2007, 7:94 http://www.biomedcentral.com/1471-213X/7/94
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Anion-exchange HPLC fractionation of the cytosolic fraction Figure 2
Anion-exchange HPLC fractionation of the cytosolic fraction. (A) The cytosolic fraction was further fractionated using 
an anion-exchange column (Accell QMA) with a step-gradient of increasing concentrations of ammonium bicarbonate (straight 
lines). The concentrations are indicated on each step while absorbance was measured at 280 nm indicating the protein yield of 
each fraction. (B) The Coomassie blue-stained SDS-PAGE gel shows the fractionation of the cytosolic sample (total) with the 
lanes corresponding to the cytosolic fractions below the peaks of the HPLC chromatogram. Note the resulting enrichment of 
certain protein bands. Relative molecular weights of protein standards are indicated in kDa.
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els are maximal and the tail begins to regress (Fig. 8B)
[32].
Keratins range in size from 40 to 67 kDa. The keratin spot
corresponding to RLK I runs at ~24 kDa and all of the pep-
2D gel analyses of the nuclear, mitochondrial and microsomal fractions Figure 3
2D gel analyses of the nuclear, mitochondrial and microsomal fractions. Proteins from the nuclear, mitochondrial 
and microsomal fractions were separated by 2D-PAGE according to molecular weight and pI point. Total proteins were 
detected by colloidal Coomassie stain while phosphoproteins were detected in the same gel using the ProQ Diamond phos-
phoprotein-specific stain. Relative molecular weights of protein standards are indicated in kDa.
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2D gel analysis of the anion-exchange HPLC cytosolic fractions Figure 4
2D gel analysis of the anion-exchange HPLC cytosolic fractions. Proteins from each of the fractions resulting from the 
anion-exchange HPLC of the cytosolic sample were separated by 2D-PAGE according to molecular weight and pI point. The 40 
mM fraction is the unbound protein fraction, while the subsequent fractions are proteins eluted by the increasing ammonium 
bicarbonate concentration step-gradients. Total proteins were detected by colloidal Coomassie stain while phosphoproteins 
were detected in the same gel using the ProQ Diamond phosphoprotein-specific stain. Relative molecular weights of protein 
standards are indicated in kDa.
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Identification of a novel R. catesbeiana type I (RLK I) keratin fragment by 2D gel analysis Figure 5
Identification of a novel R. catesbeiana type I (RLK I) keratin fragment by 2D gel analysis. (A) 2D gel regions of the 
340 mM cytosolic, microsomal, mitochondrial, and nuclear fractions show the increase of a protein spot at ~24 kDa and pI ~5 
due to T3 treatment at 48 h. The corresponding gel region, stained with a phosphoprotein stain, is shown for the nuclear frac-
tion revealing additional changes in the phosphoproteome. The white arrows indicate the spot identified as a novel type I ker-
atin RLK I fragment in the T3 samples (see Table 1). In the phosphoprotein gel, the white arrow indicates a possible 
phosphorylated form of the keratin fragment. The gray arrows indicate an additional unidentified protein and phosphoproteins 
that are altered upon T3 treatment. Relative molecular weights of protein standards are indicated in kDa. (B) Spot density 
measurements (in arbitrary values) are graphed for the corresponding 2D gels on the left. The white bar represents the con-
trol while the gray bar represents the T3 treatment. Error bars represent the standard error of the mean from three independ-
ent controls and three independent T3 samples. Significance is indicated by an asterisk for p < 0.01 and by a black dot for p < 
0.04 (ANOVA). The values adjacent to the gray bars represent the fold increase due to T3. In the nuclear fraction (k) repre-
sents the keratin spot, while (s1) represents an additional protein spot observed to be increased, and (s2) and (s3) represent 
two phosphoproteins that were increased due to T3 treatment. Spot density measurements were normalized between the gels 
with the β-actin protein spot.
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tides that we detected in the MS analysis from the protein
spot mapped to the N-terminal end of the complete
cloned sequence (Fig. 6). Immunoblot analyses of the 48
hour microsomal fraction using a pan-cytokeratin anti-
body revealed the appearance of a similarly migrating
fragment in the T3 sample with a concomitant reduction
of protein intensity at around 50 kDa compared to the
control sample (Fig. 8C). Interestingly, the identified pep-
tides lie just upstream of what is known as a consensus
caspase cleavage site (VEMDA) identified in type I human
keratins [33] suggesting that our observed protein spot is
a caspase cleavage product of RLK I (Fig. 6). No caspase
cleavage of any keratins has previously been reported in
anurans during metamorphosis. However, a number of
effector caspases, such as caspase 3 and 7, increase in
expression and activity during metamorphosis in the tail
[34-36]. Caspase 3 is the most markedly up-regulated in
the tail. It is expressed in larval skin epidermal cells that
undergo TH-induced cell autonomous death and is
known to act on type I keratins in humans [33,37].
RLK I was also highly similar to human K19 protein. This
type I keratin and the related K18 protein form het-
erodimers with the type II keratin K8 in simple-type epi-
thelia and are a prevalent and extensively-studied group of
keratins [27,28,38]. Both K18 and K19 are known caspase
3 substrates [33]. Type I keratin caspase cleavage occurs
very early in apoptosis before the detection of DNA frag-
mentation. Type II keratins are not caspase substrates
since they lack the caspase cleavage sequence [33]. In
addition, the onset of apoptosis is associated with rapid
phosphorylation of both type I and type II keratins on
their head and tail domains. For K18, Ser52 phosphoryla-
tion controls its caspase cleavage and Ser33 phosphoryla-
tion regulates binding to 14-3-3 protein [27,33]. From our
results it is possible that our keratin fragment is also phos-
phorylated. Like K18, it contains Ser residues at positions
34 and 52. Also, the phosphoprotein stain revealed an
increased phosphoprotein spot in the nuclear fraction
positioned just slightly towards the more acidic end of the
gel relative to the RLK I fragment. This phosphoprotein
was increased at 24 and 48 h by 1.6 and 4.0 fold respec-
tively which matches the increase of the total-protein ker-
atin spot (Fig. 5A and 5B). Although this phosphoprotein
could not be identified by MS, its more acidic position
adjacent to the RLK I fragment suggests it could be a phos-
phorylated form of the same fragment.
The reasons for keratin cleavage and phosphorylation are
not well understood and are speculated to function as
phosphate sinks, for filament re-organization during
apoptosis, or mechanisms that protect cells from apop-
totic damage allowing a graded sequence of events. In
human cancer therapy, the appearance of the caspase
cleavage products of K18 and K19 in patient serum are
used as indicators of cancer prognosis and apoptotic
death of tumor cells undergoing chemotherapy [39,40].
The ease with which this fragment was detected in our
immunoblot using a pan-cytokeratin-specific antibody
suggests that it could be used as a protein marker for the
induction of a TH response in tadpoles which may be per-
turbed upon exposure to disruptors of TH action. The very
early appearance of this fragment during precocious tail
metamorphosis before the detection of any overt apop-
totic events [9] is very intriguing. It is currently unclear
whether the appearance of this keratin fragment is a prod-
uct of initiation of the apoptotic event or is required for
tail regression to occur.
Phosphorylation changes in γ-interferon-inducible 
lysosomal thiol reductase
Three phosphoprotein spots located at 25 kDa and pI ~5
increased in abundance due to T3 at 48 h in the mitochon-
drial and microsomal protein fractions (Fig. 9A). These
spots formed a train indicating that this could be a single
protein with different posttranslational modifications.
The phosphoprotein spots increased ~5 fold, while the
only corresponding protein spot that could be detected on
the total-protein gels did not change in abundance (Fig.
9B). This indicates that T3 caused a change in the post-
translational state of the protein while its expression level
remained the same. MS analysis of the protein spot from
the microsomal and mitochondrial, control and treat-
ment samples indicated that this is the same protein spot
(data not shown). ESI-QqTOF MS/MS analysis of the tryp-
tic fragments of the protein spot provided two high qual-
ity peptide sequences (Table 2). A homology search of the
protein database with the two sequences gave the highest
match to the Xenopus tropicalis γ-interferon-inducible pro-
tein 30 (IP30) [NCBI: NP_001017196.1], more com-
monly known as gamma-interferon-inducible lysosomal
thiol reductase (GILT) [41]. This protein also matched the
observed molecular weight and pI point.
GILT is the specific lysosomal enzyme responsible for
thiol reduction of proteins in the endocytic pathway for
antigen presentation [41]. Gamma interferon (IFNγ)
released by activated T cells, increases antigen presenta-
tion on antigen presenting cells (APCs) such as macro-
phages, dendritic cells, and B cells through the induction
of major histocompatability complex II (MHCII) mole-
cules and related proteins. In addition, IFNγ increases the
constitutive expression of GILT in APCs and even induces
GILT expression in non-hematopoietic cells such as
fibroblasts, keratinocytes and endothelial cells [42]. GILT
is transported in its proform (30–35 kDa) from the ER
and Golgi complex into the early endosomes of the endo-
cytic pathway where it is combined with MHCII-invariant
chain containing vesicles and converted into its mature
form (25–30 kDa) by the removal of N- and C-terminalBMC Developmental Biology 2007, 7:94 http://www.biomedcentral.com/1471-213X/7/94
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prosequences in the late endosomes and lysosomes
[41,43]. It is likely that the GILT protein we identified is
the mature form of the protein due to its localization in
the microsomal and mitochondrial fractions (which con-
tain vesicles from the ER, Golgi and lysosomes), the size
on the 2D gels, and scope of coverage of identified pep-
tides.
Further analyses of the phosphoprotein spots using 2D
immunoblots and antibodies specific for the three com-
mon phospho-amino acids, phosphoserine, phospho-
threonine, and phosphotyrosine did not give any
indication that the GILT protein is differentially phospho-
rylated on any of those residues (data not shown), while
the ProQ Diamond phosphoprotein stain reproducibly
detected a change in phosphorylation. As with many lys-
osomal enzymes, GILT is a glycoprotein with three poten-
tial N-linked glycosylation sites. Furthermore, mature
GILT contains mannose-6-phosphate (M6P) on one or
more of the glycan chains [41]. Phosphorylation of man-
nose within the N-linked glycan chain is a signal recog-
nized in the Golgi complex by the M6P receptor that
targets lysosomal enzymes to the endocytic pathway [44].
Therefore, it is possible that the ProQ Diamond phospho-
protein stain is detecting a phosphate in M6P and that our
observed increase in phosphorylation of GILT indicates
an increased amount of M6P-containing GILT being
directed into the endocytic pathway due to T3. In accord-
ance with this idea of increased endocytic pathway activ-
ity, the lysosomal endoprotease, cathepsin D, increases in
expression due to T3  in our iTRAQ experiment (see
below). Cathepsin D, with other lysosomal cathepsin pro-
teases (B, L and S) also converts the proform of GILT into
its mature form by cleaving off the N- and C-terminal
prosequences [43,45]. A GILT knock-out study in mice,
showed that GILT is required for the presentation of
disulfide-containing antigens and the resulting T cell acti-
vation [46]. These ideas, and the additional observation
of increased immunoglobulin (Ig) heavy chains from our
iTRAQ experiment (see below), indicate that T3 must be
stimulating antigen presentation and possibly in turn acti-
vating T cell and finally Ig-producing/possessing B cell
lymphocytes.
Additional changes observed in the 2D gel analysis
Within the region of the keratin spot, additional proteins
and phosphoproteins were increased in the nuclear frac-
tion (Fig. 5A). A protein spot that could not be identified
increased by 2 (data not shown) and 3.5 fold at 24 and 48
h, respectively (Fig. 5B). And two unidentified phospho-
proteins were increased only at 48 h by ~5 fold (Fig. 5A
and 5B). A protein spot located at 30 kDa and pI ~5.5 in
the microsomal fraction was increased by 2.4 fold at 48 h
upon T3 exposure [see Additional file 1]. Amino acid
sequence was obtained with high confidence for three
peptides from this spot but no significant homology
match could be made [see Additional file 2].
Differential expression analysis using iTRAQ
2D gel analysis has the advantage of identifying specific
protein isoforms and posttranslational modifications of
whole proteins. This whole-protein analysis approach is
limited by the inability to observe hydrophobic proteins
and proteins with extremes in size or pI [47]. In contrast,
Table 1: MS analysis of protein spot identified to be a type I keratin fragment
Observed peptide mass 
(Da, [M+H]+)1
Peptide sequence from 
MS/MS2
Identified by MALDI-
TOF-TOF3
% confidence4(MS/MS/
MALDI)
Matched database 
sequence5
807.4 LAADDFR Yes 84/89 LAADDFR
809.4 LASYLDK Yes 100/na LASYLEK
991.5 FENELALR Yes 100/98 FENELALR
1041.6 LVLQIDNAR Yes 100/100 VVLQIDNAK
1073.6 ILAATIDNSR Yes 100/100 ILSATIDNSR
1079.5 VLDELTMSR Yes 100/74 VLDELTLAR
1184.6 YYDIINDLR - 96/- YFEIISDLR
1202.6 QSVEADINGLR - 43/- QSVETDINGLR
1224.6 NHEEELQVAR - 73/- NHEEEMSIAK
1232.7 - Yes -/100 LKFENELALR
1301.6 ALEAANTELELK - 93/- ALEAANADLELK
1Observed peptide masses resulting from the tryptic digestion of the protein spot, reported as singly charged. 2Peptide sequence information 
deduced from MS/MS spectra of the corresponding peptides from ESI-QqTOF analysis. The masses of isoleucine are indistinguishable from leucine 
in MS and therefore L can be I and vice versa. 3Indicates which peptides were additionally observed with MALDI-TOF-TOF analysis. 4Percent 
confidence for the peptide sequences as reported by PEAKS software for the ESI-QqTOF spectra and by MASCOT for MALDI-TOF-TOF data. 
5Highest homology match from protein database searching with the observed peptide sequences to X. laevis type I keratin 47 kD using SPIDER 
software. Bold lettering indicates differences between the observed and database sequences.BMC Developmental Biology 2007, 7:94 http://www.biomedcentral.com/1471-213X/7/94
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RLK I cDNA and derived amino acid sequence and location of MS/MS peptide fragments Figure 6
RLK I cDNA and derived amino acid sequence and location of MS/MS peptide fragments. The complete nucle-
otide sequence (lower case) of RLK I cDNA is shown. Underlined nucleotide sequences indicate all the in-frame stop codons, 
the first methionine codon, and a consensus AATAAA polyadenylation signal. Numbers on the right indicate nucleotide posi-
tion. Upper case letters indicate the deduced amino acid sequence (single letter code). Boxed sequences indicate tryptic pep-
tides observed in the MS analyses of the RLK I protein spot from the 2D analysis. The underlined VEMDA sequence indicates a 
consensus caspase cleavage site identified in human type I keratins with the black inverted-triangle indicating the cleavage site. 
Black dots adjacent to two serine residues indicate possible phosphorylation sites based on those found in human K18 at Ser33 
and Ser52 (here Ser34 and Ser52). Numbers on the left indicate amino acid position.
gtagcagagcagctacctcgctgcgatctattgaaagtcatcccttgagccacactttttc 61
cttctaacacattctctgggtcagagcaaaaccacaaatacatccaccatggccgggcgt 121
  M  A G R
tttagctcagcatcatatcaagtttccagctctggcggtggctatggaggtggttatggt 181
  S S A S  Y  Q  V  S  S S G G  G  Y  G  G  G Y G
ggtggtggcagcagctttgcaggaggtagctatggtggaagcagctttggtgcaggcggt 241
  G G S S  F  A  G  G  S Y G G  S  S  F  G  A G G
ggctatggcagtggctatagcagcggctttggttcaggctttggtggcggatccggcggt 301
  Y G S G  Y  S  S  G  F G S G  F  G  G  G  S G G
ggcggatccggtggtggcttttccttcagctcttcttcaggttttggaggagcaggatcc 361
  G S G G  G  F  S  F  S S S S  G  F  G  G  A G S
agcagcctgggcatgggtggaggcgagaagcagacaatgcagaacctcaatgaccgcctg 421
  S L G M  G  G  G  E  K Q T M  Q  N  L  N  D R L
gcctcctacctagacaaagtcagggccctggaagcagccaacactgagcttgagctcaag 481
 A  S Y L D  K  V  R  A  L E A A  N  T  E  L  E L K
atccgccagtggtacgagaagcaagttggcgttggtgttagcggtggagacaaagactac 541
  R Q W Y  E  K  Q  V  G V G V  S  G  G  D  K D Y
agcaagtactatgatatcatcaatgacttgagaagcaagatcctagctgccactattgac 601
  K Y Y D  I  I  N  D  L R S K  I  L  A  A  T I D
aactctcgcatcgtcctgcaaattgacaacgcaaggctggctgctgatgacttcagactt 661
 N  S R I V  L  Q  I  D  N A R L  A  A  D  D  F R L
aagtttgagaatgaactggctctccgccagagtgtggaagcagacattaatggcctccgc 721
  F E N E  L  A  L  R  Q S V E  A  D  I  N  G L R
aaagtcctggatgagctcacaatgtccagaggagaccttgaactccagattgagagcctg 781
  V L D E  L  T  M  S  R G D L  E  L  Q  I  E S L
gctgaagagctggcctacctcaagaagaaccatgaggaggagttacaagttgcaagaagc 841
  E E L A  Y  L  K  K  N H E E  E  L  Q  V  A R S
agtgccactggccaggtcaacgtagagatggatgctgctccaggtatagacctcactaag 901
  A T G Q  V  N  V  E  M D A A  P  G  I  D  L T K
attctgaatgacatgagggccgactatgaacttttggctgaaaagaaccgcagagaagct 961
  L N D M  R  A  D  Y  E L L A  E  K  N  R  R E A
gaggcacagtttgcacagaagagcaatgaattgaagaaggaaatttcagttggtgtggaa 1021
  A Q F A  Q  K  S  N  E L K K  E  I  S  V  G V E
caggtgcagacaaccaagagcgaaatctccgacctcagacgtaccctccaaggcttagag 1081
  V Q T T  K  S  E  I  S D L R  R  T  L  Q  G L E
attgagctgcagtctcagctggcaatgaaaaaatcccttgaagacacccttgcagaaaca 1141
  E L Q S  Q  L  A  M  K K S L  E  D  T  L  A E T
gaaggccgttatggaggacagctccagcagctccagaatgtcatcagcggattagaagaa 1201
  G R Y G  G  Q  L  Q  Q L Q N  V  I  S  G  L E E
cagctcatacagatcagacaagacatggaacgccagagcatggagtacagagagctgctt 1261
  L I Q I  R  Q  D  M  E R Q S  M  E  Y  R  E L L
gacatcaagaacaggctagagatggaaattgaaacataccgccgcctgctggaaggagaa 1321
  I K N R  L  E  M  E  I E T Y  R  R  L  L  E G E
ctaggtcaattctcccagagctcttcttcatcaagctcagcaagcaaaggtgcctcctca 1381
  G Q F S  Q  S  S  S  S S S S  A  S  K  G  A S S
tcagtttccacctcacagatttcctcatcatccacaacaaaatcacagacatcttctata 1441
  V S T S  Q  I  S  S  S S T T  K  S  Q  T  S S I
gattccaaaaaagacccaaccaaaaccagaaaggtgaagaccatcgttgaagaagtgata 1501
  S K K D  P  T  K  T  R K V K  T  I  V  E  E V I
gatggaaaagtcgtgtcctcaaaggtagtggagaaagaagaaatgatgacttaaaaagaa 1561
  G K V V  S  S  K  V  V E K E  E  M  M  T
aagcaacattgaaggaagacaccctgtggacttgaaaaggtggtgctggcttgtggcggg 1621
cactttaacaattcttttgctacaaatgaataagacatgaagttgtttctctttttgatt 1681
caataaaaattttcttgcaaaaaaaaaaaaaaaaaaaaaaaaaaaaa 1728
105
165
 F 5
 G 25
 G 45
 G 65
 S 85
 I 125
 S 145
 K 185
 K 205
 A 225
 S 245
 I 265
 E 285
 Q 305
 I 325
 E 345
 Q 365
 D 385
 L 405
 S 425
 D 445
 D 465BMC Developmental Biology 2007, 7:94 http://www.biomedcentral.com/1471-213X/7/94
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Multiple sequence alignment of the derived amino acid sequence of RLK I Figure 7
Multiple sequence alignment of the derived amino acid sequence of RLK I. The derived amino acid sequence of RLK 
I [GenBank: EF156435] was aligned with the X. laevis type I keratin 47 kDa protein [GenBank: P05781] (Xl 47 kDa), a partial R. 
catesbeiana adult type I keratin RAK [GenBank: BAB47394.1] (RAK), the human type I keratin K19 [GenBank: NP_002267.2] (h 
K19), and the R. catesbeiana larval type II keratin RLK [GenBank: BAB47395] (RLK II) sequences. Gaps that were inserted for 
optimal alignment are indicated by a dash. Identical amino acids are shaded. Numbers indicate amino acid position for each 
sequence. The alignment was done using ClustalW software [22].
RLK I           ---------MAGRFSSASYQVSSSGGGYGGGYGGGGSSFAGGSYGGSSFGAGGGYGS--- 48
Xl 47kDa        ---------MSFR-SSSSYSLQSKGISGGGGYGAG--------FGG---GSGAGFGG--- 36
RAK             --------------------------GFGGGYGGAG--------GG---GFGGGSGG--- 20
h K19           ----------------------MTSYSYRQSSATSS-------FGG---LGGGSVRF--- 45
RLK II          MSQFKQFGGGAQRKGFSSFSVSRSSGSFGSAGGAGG-------AGGAGGAGAGGFGSRSL 53
RLK I           --------------GYSSGFGS-GFGGGSGGG----GSGGGFSFSSSSGFGG---AGSSS 86
Xl 47kDa        --------------GSGAGFGG-GYGAGFGGG----ASSG-FSLSSAGGFGA---AAASS 73
RAK             --------------AGGGGFAG-GYG-GAGGG----GFAGGYGGAGGGGFGG---GGFGA 57
h K19           --------------GPGVAFRAPSIHGGSGGRGVSVSSARFVSSSSSGAYGGGYGGVLTA 91
RLK II          FNVGGRRTISISTAGGQGGYGGMGFGVGVGGGGFG-GGAGGFGQGFGSGGAQAGIQEVTI 112
RLK I           --LGMGGG--------------EKQTMQNLNDRLASYLDKVRALEAANTELELKIRQWYE 130
Xl 47kDa        SFSNFGGN--------------DKQTMQNLNDRLASYLEKVRALEAANADLELKIREWYE 119
RAK             GGGLLATN--------------EKQTMQNLNDRLATYLDKVKSLEDGNTELERKIKEWYE 103
h K19           SDGLLAGN--------------EKLTMQNLNDRLASYLDKVRALEAANGELEVKIRDWYQ 137
RLK II          NQSLLAPLNLEIDPEIQKVRVQEREQIKTLNNKFASFIDKVRFLEQQNKVLETKWSLLQE 172
RLK I           KQV-GVGVSGGDKDYSKYYDI-INDLRSKILAATIDNSRIVLQIDNARLAADDFRLKFEN 188
Xl 47kDa        KQK-GSGIGAGSKDFSKYFEI-ISDLRNKILSATIDNSRVVLQIDNAKLAADDFRLKFEN 177
RAK             NQRPGSTTGAGAADYSKYFDT-IDDLRNKILSATIENSKYILQIDNARLAADDFRLKYEN 162
h K19           KQG-----PGPSRDYSHYYTT-IQDLRDKILGATIENSRIVLQIDNARLAADDFRTKFET 191
RLK II          QGGQFKGGARGKSNIEAIFDAYINSLKRQLDALQNDKYRLDGELRNMQDLVDDFKNKYED 232
RLK I           ELALRQSVEADINGLRKVLDELTMSRGDLELQIESLAEELAYLKKNHEEELQVARSSATG 248
Xl 47kDa        ELALRQSVETDINGLRRVLDELTLARGDLEMQIESLTEELAYLKKNHEEEMSIAKSSSAG 237
RAK             ELALRQSVEADINGLRRVLDELTMSRSDLELQIESLTEELLYLKKNHAEEMGSLAGGETG 222
h K19           EQALRMSVEADINGLRRVLDELTLARTDLEMQIEGLKEELAYLKKNHEEEISTLRGQVGG 251
RLK II          EINKRTSAENDFVVLKKDVDAAYMNKVELEAKVDALTDEINFLRTLYEQEMGQLQAQISD 292
RLK I           -QVNVEMDAAPGIDLTKILNDMRADYELLAEKNRREAEAQFAQKSNELKKEISVGVEQVQ 307
Xl 47kDa        -QVNVEMDAAPGIDLNKILSDMRADYETLAEKNRRDAELWFNQKSGELKKEIQTGVEQVQ 296
RAK             -QVTVEMNAAPGIDLTKILNDMREQYEAMAEKNRKDAEAQFLQQSNGLKKEISAGVAEVQ 281
h K19           -QVSVEVDSAPGTDLAKILSDMRSQYEVMAEQNRKDAEAWFTSRTEELNREVAGHTEQLQ 310
RLK II          TSVVLSMDNNRNLDLDSIIAEVKAQYEEIAKRSRSEAEATYSVKVKELQASAGAQGDVLR 352 
RLK I           TTKSEISDLRRTLQGLEIELQSQLAMKKSLEDTLAETEGRYGGQLQQLQNVISGLEEQLI 367
Xl 47kDa        TSKSEINDLRRSLQSLEIELQSQLAMKKSLEDTLAETDGRYGAQLQTIQFSLRSLEEQLL 356
RAK             TKSTEITDLRRTLQSLEIELQSQLAMKKRLEQTLAETEGRYCAQIAKLKDIIDGVEEQLS 341
h K19           MSRSEVTDLRRTLQGLEIELQSQLSMKAALEDTLAETEARFGAQLAHIQALISGIEAQLG 370
RLK II          NTKNEISELNRKLQRLRAEIENVKKQNAKLQTAIAEAEDRGELVLKDAHAKLAELEAALQ 412
RLK I           QIRQDMERQSMEYRELLDIKNRLEMEIETYRRLLEGELGQFSQSSSSSSSASKGASSSVS 427
Xl 47kDa        QIRSDMERQNMEYRQLLDIKTRLEMEIETYRRLLEGEFGSLKSSIVQAT--------EVS 408
RAK             QIRFDTERQSDQYRQLLDIKSRLEKEIEQYRILLEGGGGSLGLSSSSST----------- 390
h K19           DVRADSERQNQEYQRLMDIKSRLEQEIATYRSLLEGQEDHYNNLSASKVL---------- 420
RLK II          KAKQEMARQLREYQELMNTKLALDVEIATYRKLLEGEETRLSTDSNVSISVVSGKTSLAS 472
RLK I           TSQISSSSTTKSQ-------------TSSIDSKKDPTKTRKVKTIVEEVIDGKVVSSKVV 474
Xl 47kDa        TSQSSSS------------------------SKKD------------------------- 419
RAK             TQKSTGS-----------------------VGSKDSSKTRKIMTFYEEIENGRVISTSKK 427
h K19           ------------------------------------------------------------
RLK II          GGGGAGGSFGGGFGAGGGFGAGGGFGAGGGYGAGGSGGSAGGFGFSSGSSSGYGLSAGGG 532
RLK I           EKEEMMT---------- 481 
Xl 47kDa        ----------------- 
RAK             ESIEKM----------- 433 
h K19           ----------------- 
RLK II          GGSGSVRFVSSQSSYRS 549BMC Developmental Biology 2007, 7:94 http://www.biomedcentral.com/1471-213X/7/94
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MS analysis techniques circumvent this limit by analyzing
peptides derived from trypsin-cleaved protein samples.
However MS peptide analysis has limitations in distin-
guishing between protein isoforms that potentially share
identical peptides [48]. Consequently, 2D gel analysis and
MS analysis techniques are complementary methods that
can be combined to study differential protein expression.
Therefore, to increase the number of observed altered pro-
teins, changes in protein expression in the R. catesbeiana
tadpole tail fin were additionally assessed using the novel
MS technique, iTRAQ [49].
The iTRAQ labeling reagents are four unique chemical
tags (114, 115, 116 and 117) that label peptides on pri-
mary amines allowing for the quantitation of relative pro-
tein abundance in four samples simultaneously during a
single analysis (Fig. 10). Each sample is labeled with a dif-
ferent tag. The tags are isobaric, meaning that identical
peptides from four different samples will be observed in
the MS analysis as a single peptide. Peptide fragmentation
and tandem-MS (MS/MS) analysis of that peptide then
allows peptide sequence information to be acquired lead-
ing to a protein inference. In addition, different reporter
ions are generated from the tags after peptide fragmenta-
tion at 114, 115, 116 and 117 m/z in the MS/MS spectra,
representing each of the four samples, indicating the pro-
teins' relative abundance. Relative abundance is obtained
by measuring the area underneath the reporter peaks and
is reported as a ratio between the samples. In our case, the
data is reported as the average ratio of the T3 treatment ver-
sus the control from two duplicate experiments. A ratio
above 1 indicates the fold increase in expression due to T3
exposure, while a ratio below 1 indicates a reciprocal fold
decrease in expression.
Traditionally, iTRAQ data analysis is performed automat-
ically with software, which greatly reduces the analysis by
the end-user. The success of obtaining valid data in this
manner, however, is first dependent on the protein iden-
tification obtained using software, such as MASCOT,
where an identification is reliant on a perfect match of ion
peaks in a MS/MS spectrum to an existing protein in the
protein sequence database [50]. This method works well
for the analysis of organisms with extensive entries in gene
and protein databases but results in many unidentified
spectra when less well-defined species, such as R. catesbe-
iana, are analyzed. Additionally, when a high quality par-
tial MS/MS spectrum is obtained (yielding partial peptide
sequence information) software limitations do not permit
identification when using ion peaks database searching.
To remedy these problems, we first analyzed the raw
iTRAQ data using Excel spreadsheets to find all the MS/MS
spectra that showed significant changes in expression due
to the T3 treatment. The resulting MS/MS spectra were de
Changes in transcript and protein fragment levels of RLK I in  the tail fin Figure 8
Changes in transcript and protein fragment levels of 
RLK I in the tail fin. (A) Fold change in steady-state levels 
of the keratin transcript relative to time-matched controls 
after 100 nM T3 exposure for 24, 48 and 72 h. White bars 
represent controls and gray bars represent T3 treatments. 
Error bars represent the standard error of the mean (n = 4 
for all treatments). Significance is indicated by an asterisk for 
p < 0.03 (Mann-Whitney U). (B) Fold change in steady-state 
levels of the keratin transcript at different stages of natural 
metamorphosis relative to premetamorphic TK stage VI-VIII 
[31]. Error bars represent the standard error of the mean (n 
= 4 for all treatments). Significance is indicated by a double 
asterisk for p < 0.002 (Mann-Whitney U). (C) Immunobloting 
microsomal fraction samples using anti-pan-cytokeratin anti-
body reveals the appearance of the keratin fragment (25 
kDa) and a concomitant loss of keratin at 50 kDa due to 10 
nM T3 treatment. Relative molecular weights of protein 
standards are indicated in kDa. Shown is a representative of 
two independent experiments.
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novo sequenced manually and/or using additional soft-
ware (PEAKS) [51]. The resulting peptide sequences were
then used to query protein databases using BLASTp. This
resulted in substantially higher identification of proteins
due to homologous matches or identical matches origi-
nally missed by MASCOT.
To increase the proteome coverage and quantitation accu-
racy, the iTRAQ samples were analyzed three times on an
ESI-QqTOF mass spectrometer (Fig. 10) [52]. As shown in
Table 3, many of the peptides that showed changes in
abundance due to T3 treatment overlapped between the
runs. The mass spectrometer collected 6249 to 7682
unique MS/MS spectra per run. Out of those, ~0.3% of the
spectra with high quality iTRAQ reporter tags represented
peptides that changed according to our criteria of 1.5 fold
or higher. In total, 41 unique spectra showed an increase
or decrease of 1.5 fold or higher due to the T3 treatment.
Successful  de novo peptide sequence information was
obtained for 34 (83%) of those spectra. Nineteen (56%)
of those amino acid sequences were identified with
homology protein database searching. Only three of the
19 peptides were identified using the standard database
matching method that requires a perfect match to a pro-
Phosphorylation changes in γ-interferon-inducible lysosomal thiol reductase (GILT) Figure 9
Phosphorylation changes in γ-interferon-inducible lysosomal thiol reductase (GILT). (A) Phosphoprotein 2D gel 
regions of the mitochondrial and microsomal fractions showing the increase in a row of phosphoprotein spots (s1, s2, s3) due 
to T3 treatment at 48 h, while a corresponding total-protein stained 2D region shows no change in the only detectable protein 
spot s2 (gray arrows). Relative molecular weights of protein standards are indicated in kDa. (B) Spot density measurements (in 
arbitrary values) are graphed for the corresponding 2D gels on the left. The white bar represents the control while the gray 
bar represents the T3 treatment. Error bars represent the standard error of the mean from three independent controls and 
three independent T3 samples. Significance is indicated by an asterisk for p < 0.01 and by black dot for p < 0.1 (ANOVA). The 
values adjacent to the gray bars represent the fold increase due to T3. Phosphoprotein spots s1, s2, and s3 increase while the 
corresponding protein spot s2 does not change. MS analysis of the only detectable protein spot s2 (gray arrow) is indicated in 
table 2. Spot density measurements were normalized between the gels with the β-actin protein spot.
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tein database using MASCOT software. These 19 peptides
represent at least 11 different proteins, 5 of which
increased and 6 of which decreased in abundance due to
T3 exposure.
The same iTRAQ samples were also analyzed using a
MALDI-TOF-TOF mass spectrometer (Fig. 10) to obtain
additional proteome coverage because the peptide ioniza-
tion characteristics are different from the ESI-QqTOF. Due
to software limitations no de novo sequencing of raw MS/
MS spectra was performed and the data was analyzed
using the standard method of database searching using
the observed MS/MS spectra ion peaks using MASCOT.
The MALDI-TOF-TOF analysis identified 3352 peptides
with over 95% confidence. These peptides represented
729 unique proteins, of which 50% were identified
through a single peptide. Four proteins showed altered
abundance ≥ 1.5 fold due to the T3 treatment. One of these
proteins had an increased abundance while three had a
decreased abundance. Details of the iTRAQ results are pre-
sented in Table 4. Interestingly, some of these proteins
have established functional connections that may be
important during tail regression. In addition, some of the
proteins have connections to those identified in the previ-
ous 2D gel analyses. The identified proteins are involved
in apoptotic events, modulation of the extracellular
matrix, immune system, metabolism, mechanical func-
tion, and oxygen transport and are discussed in detail
below.
Immune system components
T3 induces the activation of the immune system as is evi-
dent with the increased maturation of GILT as revealed in
the 2D analysis. In addition, this is apparent from an
increase in immunoglobulin chains and cathepsin D and
is possibly related to the decrease of a coatomer protein.
Six peptides that increased 1.5–4.6 fold matched a type of
immunoglobulin heavy chain (Table 4). The peptides
matched sequences from X. laevis as well as from other
species. The peptides were derived from constant and var-
iable regions of the heavy chain, and one matched the IgM
heavy chain isotype.
The immune system plays a major role during the meta-
morphic process. Macrophages increase in the regressing
tadpole tail in number and phagocytic activity removing
apoptotic bodies of dying muscle cells [53]. Larval lym-
phocyte populations rise in the growing tadpole, decrease
sharply at climax of metamorphosis, and expand again
with adult lymphocytes [54]. The exchange in lymphocyte
populations appears to be required for the tolerance of
new adult antigens and for the removal of larval tissues
that are seen as 'non-self' in the metamorphosing animal.
X. laevis tail cells possess larval antigens that stimulate the
immune system of a syngeneic adult or a metamorphos-
ing animal [55]. Izutsu and coworkers have shown that a
59 kDa larval antigen expressed specifically by tail epider-
mal cells only during metamorphosis causes increased
proliferation of newly arising adult-type T lymphocytes,
eventually leading to the destruction of tail fin tissue by
cytotoxic T lymphocytes (CTL) and natural killer cells
(NK) [56,57]. Collaboration between T- and B-cell types
must occur for NK cell activation and may explain our
observation of increased immunoglobulin heavy chains
which can only come from B cell activation. A reported
peptide sequence from the 59 kDa antigen is homologous
to keratin α, and points at the possibility that the
Table 2: MS analysis of protein spot identified as GILT
Observed peptide mass 
(Da, [M+H]+)1
Peptide sequence from 
MS/MS2
% confidence3 Matched database 
sequence4
E value5
1399.8 (CL)FNLVTELYK 100 (98) Observed 1 
CLFNLVTELYK 11
LFNLV + YK
1877
Database 223 
SLFNLVCDTYK 233
1405.7 (TV)LDCVDGDLGNK 100 (90) Observed 1 
TVLDCVDGDLGNK 13
TVL+CV+GDLGNK
0.001
Database 172 
TVLECVNGDLGNK 184
MS analysis of the only detectable protein spot s2 (gray arrows in Fig. 9). 1Observed peptide masses resulting from the tryptic digestion of the 
protein spot s2, reported as singly charged. 2Peptide sequence information deduced from MS/MS spectra of the corresponding peptides from ESI-
QqTOF analysis. The masses of isoleucine are indistinguishable from leucine in MS and therefore L can be I and vice versa. 3Percent confidence for 
the peptide sequences, as reported by PEAKS software for the ESI-QqTOF spectra. 4Highest homology match from protein database searching with 
the observed peptide sequences to X. tropicalis GILT. Indicates the sequence alignment of the observed peptide to the identified protein (Database) 
as aligned by BLASTp. The sequence in between indicates the matching and similar (+) amino acids between the two sequences.5From BLASTp 
alignments.BMC Developmental Biology 2007, 7:94 http://www.biomedcentral.com/1471-213X/7/94
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iTRAQ analysis Figure 10
iTRAQ analysis. Two control and two treatment samples were each labeled with one of the four iTRAQ tags as shown. The 
peptide samples were pooled, fractionated by two dimensions of liquid chromatography (cation-exchange and reverse-phase), 
and analyzed by MS. The iTRAQ sample was analyzed three times on an ESI-QqTOF mass spectrometer and once on a MALDI-
TOF-TOF mass spectrometer. The image shows a sample MS/MS spectrum of a single peptide from which the amino acid 
sequence is deduced, and in addition, it reveals the four reporter ions (enlarged region) from the iTRAQ tags, in the low-mass 
region, whose intensity indicates the relative abundance of that peptide in the four samples. The two controls are labeled with 
tags 114 and 116, and show reporter ions at that m/z, while the two T3 treatment samples are labeled with tags 115 and 117, 
showing reporters at those m/z. This spectrum reveals an increase in that peptide due to T3.
Two Control
samples
Two T3-induced
samples
Reduce, block Cys,
and trypsin digest
Reduce, block Cys,
and trypsin digest
iTRAQ label
114, 116
iTRAQ label
115, 117
Pool samples
Cation-exchange
Chromatography
Reverse-phase
Chromatography
Reverse-phase
Chromatography
Nanospray ESI-
QTOF Analysis
MALDI-TOF/TOF
Analysis
114
115
116
117
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increased keratin fragment observed in the 2D gel analy-
ses may be a larval antigen produced to direct the involve-
ment of the immune system.
A peptide that increased by 1.7 fold was identified in the
MALDI-TOF-TOF analysis corresponding to a putative
Xenopus cathepsin D protein (Table 4). Cathepsin D is a
lysosomal aspartyl protease that has been previously
implicated in tadpole tail regression [58,59]. The increase
in cathepsin D may be related to GILT maturation inside
the lysosomes and a resulting increase in antigen presen-
tation as discussed above.
A subunit γ protein of the coatomer protein complex
(COPI) corresponding to the X. laevis MGC68533 protein
decreased by 1.6 fold in the MALDI-TOF-TOF analysis
(Table 4). Protein transport between the ER and Golgi
compartment is mediated by these non-clathrin-coated
vesicular coat protein complexes [60]. COPI is composed
of seven unique subunits and coats the vesicles on the
cytoplasmic side as they are transported from one
organelle to another. COPI is mainly associated with ret-
rograde transport of vesicles from the Golgi back to the ER
to retrieve escaped ER-resident proteins and vesicle
machinery. The γ subunit binds double lysine motifs in
the transmembrane proteins targeted for return to the ER.
Interestingly, GILT and other lysosomal zymogens have
dilysine motifs which are used as cleavage sites during
enzyme maturation. There have not been any previous
associations of COPI with TH or metamorphosis, but it is
possible that T3 causes a specific change in vesicle traffick-
ing to accomodate tail regression. This change may con-
tribute to an increase in mature GILT in the lysosomes as
is observed on the 2Ds of the microsomal and mitochon-
drial fractions.
Extracellular matrix components and modifier proteins
Changes in the extracellular matrix (ECM) of the regress-
ing tadpole tail have been well documented [1]. Four pro-
teins involved in ECM structure and modification were
identified by iTRAQ (Table 4).
The plasma proteinase inhibitor, α-2-macroglobulin
(A2M), was decreased 1.5 fold upon T3 treatment (Table
4). A2M is synthesized by several cell types such as hepa-
tocytes, lung fibroblasts and monocyte-macrophages, and
functions to trap and facilitate clearing of proteases such
as trypsin, thrombin and collagenases [61,62]. Tissue-spe-
cific A2M synthesis is independent of plasma A2M and
serves a compartmentalized function such as the regula-
tion of tissue proteinases such as matrix metalloprotein-
ases. Since there is an increase in matrix metalloprotease
activity in the tadpole tail in TH-induced and natural met-
amorphosis [1], the observed decrease in the A2M levels
could be a result of an organized downregulation to allow
for ECM remodeling or A2M and metalloprotease cova-
lent linkage and subsequent removal and degradation of
the proteins. Recently, Lin et al. observed a T3-dependent
decrease in A2M transcripts in a human hepatocellular
carcinoma cell line [63].
A peptide matching inter-α inhibitor H4 protein increased
by 2.1 fold (Table 4). The H4 polypeptide is a less
described component of the trimeric plasma serine pro-
tease inhibitor, inter-α inhibitor (IaI), more commonly
composed of the H1, H2 and bikunin polypeptides
[64,65]. IaI proteins are linked to inflammation processes
and ECM structure. Serine protease inhibitor activity of
bikunin regulates plasmin which is a known activator of
matrix metalloproteases [64]. The H4 polypeptide is also
a serum marker for the acute-phase response in infected
animals and humans resulting from the nonspecific
immune response [66-68] and may be an additional link
to our observation of the immune system activation.
Additionally, the H polypeptides stabilize and protect the
ECM through covalent links to ECM components and
possibly through collagen binding domains [64].
α 1 type I collagen (α 1(I) chain) was identified by two
peptides that decreased by 1.6–1.9 fold (Table 4). Type I
collagen is the most abundant member of the collagen
family and is the main constituent of the ECM [69]. It is a
major substrate of matrix metalloproteinase 1 (MMP1)
which is upregulated in R. catesbeiana tail and back skin
during natural and T3-induced metamorphosis [70,71].
Collagen (α 1(I) and α 2(I)) gene expression also
decreased under these conditions in the tail and intestine
[72-74]. It is possible that the α 1(I) collagen gene is neg-
atively regulated by a TRE-like site as in rat cardiac fibrob-
lasts [75]. Here we show that this change also occurs at the
protein level.
The last peptide associated with ECM remodeling proteins
corresponds with cortactin (Table 4). A 1.5 fold decrease
in this Src homology 3 (SH3) domain-containing protein
suggests altered tyrosine kinase signaling of actin cytoskel-
eton rearrangements [76]. Cortactin is a filamentous-actin
binding protein that stabilizes actin networks and pro-
motes actin polymerization. Since cortactin interacts with
various proteins involved in actin polymerization, endo-
cytosis (recall an overlap with GILT and cathepsin D pro-
teins) and cell-cell interactions, modification of any or all
of these processes could contribute to tail regression.
Cell metabolism proteins
Two proteins involved in cell metabolic homeostasis were
altered in abundance by T3 treatment (Table 4). The first
peptide was increased by 1.6 fold matched with a sterol
regulatory element binding protein-2 (SREBP-2). This
membrane-bound transcription factor regulates lipidBMC Developmental Biology 2007, 7:94 http://www.biomedcentral.com/1471-213X/7/94
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homeostasis through the control of genes encoding key
enzymes important in cholesterol synthesis [77]. The
SREBP transcription factors have not been implicated in
anuran metamorphosis before, however, they are
involved with TH in the mammalian context [78-80].
Recently Shin and Osborne [78] observed that T3 regulates
both SREBP-2 mRNA and nuclear protein levels, as well as
SREBP-2-controlled genes such as the low density lipopro-
tein (LDL) receptor in mice. The SREBP-2 promoter con-
tains at least one TR-binding site and is activated directly
by TR in a ligand-dependent manner [78]. It is therefore
possible that the increased level of SREBP-2 observed in
our experiments may be a direct response to T3. This
remains to be determined.
The second peptide was reduced by 1.6 fold and corre-
sponds to triose phosphate isomerase (TIM; Table 4). This
enzyme is involved in glycolysis [81] and its decrease is
compatible with a shift from glycolysis to oxidative phos-
phorylation observed during metamorphosis [82].
In addition, two proteins involved in oxygen transport
were increased upon T3 treatment. Three peptides corre-
sponding to larval hemoglobin α-III chain increased by
1.5 fold (Table 4). This protein is only found in tadpole
red blood cells (RBCs) and not adult RBCs [83,84]. In R.
catesbeiana there is a change in erythropoiesis sites and
hemoglobin types during tadpole growth and metamor-
phosis that is influenced by THs [83,85-88]. Young tad-
poles produce hemoglobin components I and II in the
kidneys, older tadpoles produce components III and IV in
the liver, and after metamorphosis, only adult hemoglob-
ins are produced in the bone marrow. This sequential
change produces hemoglobins with lower oxygen affini-
ties. Our observation of an increase in hemoglobin α-III is
indicative of an accelerated progression of hemoglobin
switching due to T3 exposure.
Consistent with a switch in hemoglobin is an 1.5 fold
increase in a peptide matching biliverdin reductase B
(BVR-B; Table 4). This enzyme is important in hemo-
globin metabolism and is predominantly found in
human fetal liver [89]. There, it produces bilirubin IXβ
from biliverdin derived from heme. Bilirubin IXβ is the
major heme catabolite during human fetal development
[90]. In adult human liver biliverdin reductase A (BVR-A)
is the major form and it produces bilirubin IXα. The
switch in this heme degradation pathway seems to be
related to the switch in hemoglobins from fetal to adult
forms.
Mechanical function and calcium modulated proteins
The abundance of peptides from muscle α-actin, myosin
heavy chain (MHC) and myosin light chain (MLC) was
reduced by exactly the same amount (2.6 fold; Table 4).
These proteins are the fundamental components of the
molecular machinery used in muscle contraction. The
peptide for muscle α-actin is distinguished from the β and
γ forms of cytoplasmic actins by a T residue instead of V in
the HPTLL sequence within this peptide. The peptide
sequence matches the R. catesbeiana cardiac  α-actin 2
sequence perfectly as well as other muscle α actins in
other species. The MHC peptide matches the R. catesbeiana
skeletal muscle MHC-3 and is distinguishable from the
other isoforms, MHCs -1, 2, 4, and 5, by three residues in
this species [91]. The MLC peptide matches the X. laevis
MLC-2 (Mylpf-prov protein) as well as MLC-2 proteins
from other species.
An embryonic/larval α-3 skeletal-actin gene has been
found in Xenopus borealis [92]. This gene was expressed in
the skeletal muscle of embryos and tadpoles, but not in
adults. However, the corresponding gene in X. laevis is
highly expressed in both adult muscle and at earlier
stages. The human skeletal muscle α-actin gene is a direct
TH response gene in cardiocytes [93,94]. The cardiac α-
Table 3: Summary of results for iTRAQ analysis by ESI-QqTOF
Run 1 Run 2 Run 3 Unique1
Unique spectra2 7682 6249 6361 n/a
Changing peptides3 17 17 21 41
de novo sequenced4 13 16 18 34
Homology matched5 87 1 1 19
MASCOT ID6 1123
Total proteins ID7 11 change: 5 up 6 down
The iTRAQ samples were analyzed three times on an ESI-QqTOF mass spectrometer. 1Indicates number of unique spectra shared between the 
replicate runs. 2Total number of unique spectra recorded per MS analysis run. These overlap by unknown amount: n/a. 3Number of spectra that 
change by ≥ 1.5 fold due to T3, have good quality reporter tags, and a ratio of the two controls between 0.67 and 1.5. 4Number of spectra for which 
amino acid sequence could be obtained through manual sequencing. 5Number of spectra for which a protein inference was made with BLASTp. 
6Indicates how many spectra were identified using the standard iTRAQ analysis with MASCOT software. 7Number of different proteins identified 
from the resulting peptides and their change in abundance.B
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Table 4: Differentially expressed proteins in the Rana catesbeiana tail fin due to T3-induction as analyzed by iTRAQ
Protein name [accession #/Species]1 Fold 
change2
Observed peptide 
mass (Da, iTRAQ 
[M+H]+)3
Observed peptide 
sequence4
% Confidence5 Matched database sequence6 E value7
INCREASED
MGC80395 protein (Sterol regulatory element-binding transcription factor 2) 
[AAH72922/Xenopus laevis]
1.6 2949.6 LTPATVET (frag.) manual Query 1 LTPATVET 8
LTPATV+T
Sbjct 184 LTPATVQT 191
136
Inter-α inhibitor H4 [XP_848765/Canis familiaris] 2.1 1789.1 V(TFE)LVYEEMLK 90–100 (53) Query 1 VTFELVYEEMLK 12
VTFELVYEE+LK
Sbjct 140 VTFELVYEELLK 151
0.004
Hemoglobin α-III chain, larval [P02011/Rana catesbeiana] 1.5 1224.7 FLSFPQTK (frag.) manual Query 1 FLSFPQTK 8
FLSFPQTK
Sbjct 33 FLSFPQTK 40
5.4
Hemoglobin α-III chain, larval [P02011/Rana catesbeiana] 1.5 1250.8 FLSFPQTK (frag.) 100 Query 1 FLSFPQTK 8
FLSFPQTK
Sbjct 33 FLSFPQTK 40
5.4
Hemoglobin α-III chain, larval [P02011/Rana catesbeiana] 1.5 2067.0 YVPHFDLTPGSADLNK 99 Query 1 YVPHFDLTPGSADLN 15
Y PHFDLTPGSADLN
Sbjct 42 YFPHFDLTPGSADLN 56
9 e-05
MGC80107 protein (Biliverdin reductase B) [AAH72790/Xenopus laevis] 1.5 1904.3 VISTPDLSHFFLR 100 Query 1 VISTPDLSHFFLR 13
VIST DLS FFLR
Sbjct 174 VISTHDLSLFFLR 186
0.26
Immunoglobulin heavy chain [AAC12909/Hydrolagus colliei] 1.6 1237.8 VVLLPPSPK 99 Query 1 VVLLPPSP 8
V+LLPPSP
Sbjct 133 VILLPPSP 140
63
Immunoglobulin heavy prechain [CAA33212/Xenopus laevis] 2.0 1817.9 SDPDQGFDGTYTVK manual Query 1 SDPDQGFDGTYTVK 14
S P++ +DGT+TVK
Sbjct 393 SAPEKAYDGTFTVK 406
52
Immunoglobulin heavy chain constant region [AAC12914/Hydrolagus colliei] 46 1391.7 LNVADWNSGK 99 Query 1 LNVA--DWNSGK 10
LNV+ DW SGK
Sbjct 69 LNVSTEDWKSGK 80
170
Immunoglobulin M heavy chain [AAO37747/Ornithorhynchus anatinus] 1.5 2065.0 FTCTVSHSDLPAPVEK 95 Query 1 FTCTVSHSDLPAP 13
FTCTVSH+DLPAP
Sbjct 446 FTCTVSHADLPAP 458
7 e-04
Immunoglobulin heavy chain variable region [AAP41191/Lepus granatensis] 1.6 1930.3 (RKQ)VVEAGGALIK 100 (92–96) Query 3 QVVEEAGGALIK 14
Q VEE+GG LIK
Sbjct 1 SAPEKAYDGTFTVK 12
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Immunoglobulin heavy prechain [CAA33212/Xenopus laevis] 1.6 1471.8 DQGFDGTYTVK manual Query 4 FDGTYTVK 11
+DGT+TVK
Sbjct 399 YDGTFTVK 406
9.2
LOC443721 protein (cathepsin D) [AAH94178/Xenopus laevis] 1.7 980.5 AYWQIR 98 (MALDI) Query 1 AYWQIR 6
AYWQIR
Sbjct 257 AYWQIR 262
42
DECREASED
α-2-macroglobulin [AAY98517/Xenopus laevis] 0.67 2195.2 AYVTV(LGD)IMGTALE
NLDR
97–100 (41) Query 1 AYVTVLGDIMGTALENLDR 19
AYVTVLGDIMGTA++NLDR
Sbjct 958 AYVTVLGDIMGTAMQNLDR 976
1 E-08
Calcium-binding protein p26olf [BAA34388/Rana catesbeiana] 0.47 1312.7 GNTTSMNFK manual Query 1 GNTTSMNFK 9
GNTTSMNFK
Sbjct 31 GNTTSMNFK 39
0.57
α1type I collagen [BAA29028/Rana catesbeiana] 0.52 2111.2 TGPAGAPGQDGRPGP
PGPPGAR
manual Query 1 TGPAGAPGQDGRPGPPGPPGAR 22
TGPAGAPGQDGRPGPPGPPGAR
Sbjct 538 TGPAGAPGQDGRPGPPGPPGAR 559
6 e-12
α1type I collagen [BAA29028/Rana catesbeiana] 0.52 2418.2 PPGPSGEK (frag.) 97 Query 1 PPGPSGEK 8
PPGPSGEK
Sbjct 912 PPGPSGEK 919
17
Caridac α actin 2 [AAX85445/Rana catesbeiana] 0.38 2244.3 VAPEEH(PT)LLTEAPLN
PK
93–100 (66) Query 1 VAPEEHPTLLTEAPLNPK 18 
VAPEEHPTLLTEAPLNPK Sbjct 98 
VAPEEHPTLLTEAPLNPK 115
3 e-09
myosin heavy chain (skeletal muscle MHC-3) [AAD13771/Rana catesbeiana] 0.39 2491.9 FQAALEEAEASLEHEEA
K
manual Query 1 FQAALEEAEASLEHEEAK 18 
FQAALEEAEASLEHEEAK
Sbjct 320 FQAALEEAEASLEHEEAK 337
8 e-09
Mylpf-prov protein (myosin light chain 2) [AAH41503/Xenopus laevis] 0.38 2098.2 NICYVITHGED (frag.) 100 Query 1 NICYVITHGED 11
NICYVITHGED
Sbjct 156 NICYVITHGED 166
0.002
MGC68533 protein (coatomer protein complex, subunit γ) [AAH61661/
Xenopus laevis]
0.61 1491.6 NAHSLYLAGVFR 99 (MALDI) Query 1 NAHSLYLAGVFR 12
NAHSLYLAGVFR
Sbjct 824 NAHSLYLAGVFR 835
0.002
Cortactin [NP_005222/Homo sapiens] 0.65 1585.9 YGLFPANYVELR 98 (MALDI) Query 1 YGLFPANYVELR 12 YLFPANYVELR
Sbjct 538 YGLFPANYVELR 549
4 e-04
Triose phosphate isomerase [NP_788764/Drosophila melanogaster] 0.64 1711.8 DIGADWVILGHSER 100 (MALDI) Query 1 DIGADWVILGHSER 14
DIGADWVILGHSER
Sbjct 185 DIGADWVILGHSER 198
7 e-06
1Name of protein for the highest scoring match that resulted with the observed peptide sequence using BLASTp (2.2.15) and the NCBI protein database (Oct. 15, 2006) searching all metazoans. The NCBI accession number and the species name 
for the identified protein are shown. 2Fold change ratios greater then 1.0 indicate a fold increase, and those below 1.0 indicate the reciprocal of fold decrease. The number is the average fold change of two replicate experiments, which consisted 
of two treatment samples and two control samples. 3Observed mass of the peptide in the MS analysis, modified with the iTRAQ reagent, reported as singly charged. 4Amino acid sequence determined for the observed peptide by manual de novo 
or automatic de novo by PEAKS software sequencing, or a MASCOT software match. (frag.) indicates that only a partial peptide sequence could be determined. The masses of isoleucine are indistinguishable from leucine in MS and therefore L 
can be I and vice versa. 5Percent confidence for the peptide sequence as reported by the PEAKS or MASCOT (MALDI) software. (MALDI) indicates that the peptide was identified in the MALDI-TOF-TOF analysis of iTRAQ samples. "manual" 
indicates that the peptide sequence was obtained manually and no percent confidence can be reported. 6Indicates the sequence alignment of the observed peptide (Query) to the identified protein (Sbjct) as aligned by BLASTp. The sequence in 
between indicates the matching and similar (+) amino acids between the two sequences. 7From BLASTp alignments.
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actin gene of rats is also inducible with T3 in heart myo-
cytes [95].
Five skeletal muscle MHC isoforms have been cloned in R.
catesbeiana [91]. No specific larval forms have been found
and all five isoforms are expressed in the tail and limb
muscle of both tadpoles and adults. In the tadpole tail
muscle, T3 increases the mRNA for MHCs -1, 3, 4, and 5 by
two to three-fold within 48 h [91]. However, in contrast,
the rate of total MHC protein synthesis was reduced by
40% at 48 h [91] consistent with our observations for
MHC-3. In fast twitch muscle fibers, MHC-3 is associated
with MLC-2 [96]. MLCs are Ca2+-signaling dependent reg-
ulators of muscle contraction and have been investigated
in X. laevis and R. pipiens but their responses to TH are not
well understood [96]. Our data suggest that MHC and
MLC expression are co-regulated.
A peptide that was decreased by 2.1 fold matched the
p26olf protein of R. catesbeiana (Table 4) The p26olf pro-
tein is a S100-like Ca2+-binding protein with the very
unique feature of having two S100-like regions [97]. Thus
far p26olf has only been found in the anurans R. catesbe-
iana, X. tropicalis and X. laevis, and appears not to have any
homologues in other vertebrates. Immunohistochemical
studies on R. catesbeiana frogs showed that p26olf prima-
rily localizes in the cilia of olfactory and lung respiratory
epithelia. p26olf may be involved in olfactory signal
transduction and a related protein, S100/A11 (calgiz-
zarin), is a key mediator of high Ca2+-induced growth
arrest and differentiation in human keratinocytes [98]. In
addition, Makino et al. [99] have shown that introducing
an N-terminal peptide of S100/A11 into human carci-
noma cell lines induced apoptosis. Thus, it may be possi-
ble that p26olf is involved in the control of apoptotic
events in the tadpole tail.
Conclusion
Genomic studies on tadpole tail regression have revealed
a number of modulated transcripts [5-9]. In comparison,
our extensive proteomic analyses showed relatively few
changes within the first 48 h of T3 treatment. This provides
support for the hypothesis that changes in the transcrip-
tome are the major target for the establishment of the tail
regression program. However, this does not imply that the
few changes in the (phospho)proteome during this time
are not important, as these changes may support the tran-
scriptome transition. For example, the tyrosine kinase
inhibitor, genistein, prevents T3-dependent tail regression
likely through inhibition of protein kinase C activity and
TRα phosphorylation [16].
Our proteomic analyses may be limited in their sensitivity
to reveal phosphorylation of low-abundance signaling
phosphoproteins since no enrichment was performed.
Nevertheless our data suggest that RLK I could be post-
translationally modified due to a T3 signal most likely
through the early action of caspases thereby indicating an
early apoptotic event. Our findings with GILT maturation,
Ig heavy chains and cathepsin D increases show that the
involvement of the immune system in the regressing tad-
pole tail may be greater than what has been generally con-
sidered. Furthermore, a large proportion of the transcripts
identified by genomic studies encode transcription factors
[5-9] whose protein products are most likely below the
detection limits of our 2D PAGE and iTRAQ analyses. An
improved fractionation strategy for the iTRAQ analysis
may reveal these.
The present study provides important insights into the
molecular mechanism of T3-dependent tadpole tail
regression during postembryonic development which
includes novel components at the proteome level.
Methods
Experimental animals
The care and treatment of animals used in this study were
in accordance with the guidelines of the Animal Care
Committee, University of Victoria, under the Canadian
Council of Animal Care.
Rana catesbeiana tadpoles were locally caught (Victoria,
BC) or purchased (Ward's Natural Science Ltd., St,
Catharines, ON). Animals were housed in the University
of Victoria aquatics facility and maintained in 360 L all-
glass flow-through aquaria containing recirculated water
at 15°C with exposure to natural daylight. Tadpoles were
fed daily with spirulina (Aquatic ELO-Systems, Inc., FL).
R. catesbeiana tadpoles, TK stage VI-VIII [31], were exposed
to 10 nM T3 (80 μl of 10-3 M T3 in 2.5 mM NaOH) (Sigma-
Aldrich, St. Louis MO USA) or vehicle control (80 μl 2.5
mM NaOH) in the rearing water (8 L per 6 tadpoles) for
24 or 48 h. Tadpoles were acclimatized for 24 h prior to
exposures to 24°C, and were not fed during this period or
during exposures. For the 2D gel analysis, each treatment
or control group consisted of 18 pooled tadpoles. The 48
hour 2D analyses consisted of three, completely inde-
pendent, control and T3 treatment groups, while the 24
hour analyses were from a single control and T3 treatment
group. The 24 hour analyses were only done to further
characterize absence or presence of proteins observed to
be altered at the 48 hour time point. For the iTRAQ anal-
ysis, two independent T3-treatment groups and two inde-
pendent control groups consisting of six pooled tadpoles
per group were used. Tadpoles were euthanized in 0.1%
tricaine methanesulfonate (Syndel Laboratories, Vancou-
ver, BC, Canada) in 25 mM sodium bicarbonate, dorsal
and ventral tail fins were removed on ice, and proteins
extracted as described below. For QPCR analysis, premet-
amorphic tadpoles (stage VI-VIII) were exposed to 100BMC Developmental Biology 2007, 7:94 http://www.biomedcentral.com/1471-213X/7/94
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nM T3 or vehicle control in the rearing water for 24, 48
and 72 h and euthanized as above. Tadpoles at the indi-
cated stages were also collected to determine gene expres-
sion in tail tissue during natural metamorphosis.
Subcellular fractionation
Two separate procedures were used for the isolation of
nuclei and for the cytosolic-mitochondrial-microsomal
fractions. All extraction procedures were performed on ice
or at 4°C. Tail fin tissue was rinsed with extraction buffer
lacking detergents or inhibitors (see below for composi-
tion). Three ml of buffer were used per gram of tissue,
which was homogenized in a teflon-glass Dounce homog-
enizer (Wheaton, USA). For the nuclear isolation tissue
was homogenized in 20 mM N-[2-Hydroxyethyl]pipera-
zine-N'-[2-ethanosulfonic acid] (HEPES) pH 7.5, 0.25 M
sucrose (ACP Chemicals Inc., Montreal Canada), 25 mM
KCl, 5 mM MgCl2 (both from BDH chemicals, Toronto
Canada), 0.5% Triton X-100, 1mM dithiothreitol (DTT),
2 mM vanadyl ribonucleoside complexes (VRCs), 100 μM
phenylmethylsulfonyl fluoride (PMSF), 4 μg/ml apro-
tinin, 1 μg/ml leupeptin, 2 μg/ml antipain, 300 μg/ml
benzamidine, 10 mM β-glycerophosphate, 0.2 mM
Na3VO4, and 1 mM NaF (all remaining from Sigma-
Aldrich).
Homogenization efficiency and integrity of nuclei was
checked with microscopy and 4'-6-Diamidino-2-phe-
nylindole (DAPI) staining for nuclei. The homogenate
was incubated on ice with shaking for 30 min then passed
through 100 μm nylon mesh cell-strainer. The homoge-
nate was centrifuged at 1000 × g for 10 min. The nuclei
were resuspended in the above extraction buffer (3 ml per
g of initial tissue), layered onto a 0.88 M sucrose cushion,
which contained everything the extraction buffer did
except for Triton X-100 and VRCs, and centrifuged at 2000
× g for 30 min. The resulting nuclear pellet was washed in
extraction buffer, without Triton X-100 and RVCs, and
centrifuged at 2000 × g for 10 min. The nuclear pellet was
stored at -70°C.
To obtain the cytosolic, mitochondrial and microsomal
fractions, tail fin tissue was homogenized in 20 mM
HEPES pH 7.5, 0.25 M sucrose, 5 mM Ethylenedinitrilo-
tetraacetic acid (EDTA) (EM Science, Gibbstown NJ USA),
1mM DTT, 100 μM PMSF, 4 μg/ml aprotinin, 1 μg/ml leu-
peptin, 2 μg/ml antipain, 300 μg/ml benzamidine, 10
mM β-glycerophosphate, 0.2 mM Na3VO4, 1 mM NaF.
The homogenate was centrifuged at 800 × g for 10 min.
The supernatant was then centrifuged at 12,200 × g for 15
min. The pellet was washed twice in extraction buffer and
centrifuged at 12,200 × g for 15 min. This mitochondrial
pellet was stored at -70°C. The supernatant was centri-
fuged at 100,000 × g for 1 hour to obtain the microsomal
pellet and cytosolic fractions which were then stored at -
70°C.
Anion-exchange HPLC fractionation of cytosolic fraction
The cytosolic fraction was first desalted using size-exclu-
sion chromatography with Sephadex G-25-M beads
(Sigma-Aldrich). Sample was kept at 4–8°C throughout
the procedure. Six ml of sample was loaded onto a 27 ml
column with 60 mM ammonium bicarbonate (EM Sci-
ence) as buffer. The eluted protein fractions in the first 7.5
ml were kept, frozen at -70°C, and lyophilized for 48 h.
The sample was reconstituted in 40 mM ammonium
bicarbonate to a concentration of 10 mg/ml. Fractiona-
tion of the desalted cytosolic sample was performed using
a Waters HPLC setup with a Waters 600S controller, 626
pump and 486 tunable absorbance detector (Waters, Mil-
ford MA USA). The column used consisted of 2 ml Accell
Plus QMA 300Å anion-exchange media packed into a AP
Minicolumn assembly (5 × 100 mm) (Waters). Five mg of
total cytosolic sample was loaded onto the column in 40
mM ammonium bicarbonate (pH 8.3), the unbound pro-
teins were captured as the 40 mM fraction. The remaining
sample was fractionated using a step-gradient of 190, 260,
340 mM and 1 M ammonium bicarbonate. The flow rate
was set at 1 ml/minute and each step was 13 min. The
detector was set at 280 nm. The fractions were collected
on ice, frozen at -70°C, and lyophilized for 48 h.
2D polyacrylamide gel electrophoresis
Proteins from the nuclear pellet were initially extracted in
an isoelectric focusing (IEF) buffer lacking ampholytes
consisting of 9.5 M urea (SigmaUltra), 4% 3-[(3-cholami-
dopropyl)dimethylammonio]-1-propanesulfonate
(CHAPS), 1% DTT, 40 mM tris(hydroxymethyl)ami-
nomethane (Tris-base) pH 8.5, 5 mM EDTA, 100 μM
PMSF, 4 μg/ml aprotinin, 1 μg/ml leupeptin, 2 μg/ml
antipain, 300 μg/ml benzamidine, 10 mM β-glycerophos-
phate, 0.2 mM Na3VO4, 1 mM NaF (all from Sigma-
Aldrich) for 15 min at room temperature. DNA was then
precipitated by adding 2% ampholytes (Pharmalyte 3–10
and 5–8 in a 2/3 and 1/3 ratio, respectively; Amersham
Pharmacia Biotech AB, Uppsala Sweden), incubating for
15 min at room temperature, and pelleting the DNA at
12,000 × g for 10 min. Ampholytes were then replaced in
the supernatent to 2% as indicated above. The mitochon-
drial and microsomal pellets and the lyophilized HPLC
cytosolic fractions were all dissolved in the IEF buffer with
the inclusion of 2% ampholytes as described above. Pro-
tein concentrations were assayed using the Bio-Rad Pro-
tein Assay (Hercules, CA USA) with protein standards
dissolved in the IEF buffer. The amount of pellet to IEF
buffer used yielded a protein extract with a protein con-
centration of 2–6 mg/ml.BMC Developmental Biology 2007, 7:94 http://www.biomedcentral.com/1471-213X/7/94
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Three hundred μg of protein for each fraction (except for
the 40 mM cytosolic fraction where 100 μg of protein was
used) were aliquoted, made up to 100 μl with IEF buffer,
solubilized for seven hours at room temperature, centri-
fuged at 12,000 × g for 10 min, and loaded onto IEF tube
gels used for the first dimension. The IEF tube gels (2.5
mm × 13 cm) consisted of 9.5 M urea, 3.897% acrylamide
and 0.104% piperazine diacrylamide (wt/vol) (Bio-Rad),
2% CHAPS, 3.875% Pharmalyte 3–10 ampholytes,
2.375% Pharmalyte 5–8 ampholytes, and 0.05% ammo-
nium persulphate (APS) (ACP Chemicals Inc.) and 0.07%
N,N,N',N'-tetramethylethylenediamine (TEMED; Sigma-
Aldrich) for polymerization.
The IEF gels were prefocused and run as described in [6]
with the following modifications. Samples were electro-
phoresed for 16 h at 450 V, then hyperfocused at 800 V for
2 h (8800 Vh total). The IEF gels were then equilibrated
using the same equilibration buffer as in [6] except the
buffer contained 65 mM DTT for 15 min, and then for 15
min in 5 ml of IEF-equilibration buffer with 136 mM
iodoacetamide (Sigma-Aldrich).
The IEF gels were then transferred onto the second dimen-
sion SDS-polyacrylamide gels (15 cm × 14 cm × 1.5 mm)
comprised of an 11% separating gel (37.5:1 acrylamide to
bis-acrylamide (Bio-Rad), 375 mM Tris-base pH 8.8, 0.1%
SDS, 0.05% APS, 0.05% TEMED) and a 4% stacking gel
(125 mM Tris-base pH 6.8, 0.1% SDS, 0.05% APS, 0.1%
TEMED). The IEF gels were overlayed with 0.5% agarose
(EM Science) in 125 mM Tris-HCl pH 6.8 with 0.05%
bromophenol blue/2% SDS. Precision Plus Dual Color
(Bio-Rad) molecular weight markers were used. The gels
were electrophoresed at 30 mA per gel at constant current
in SDS running buffer (25 mM Tris-base, 192 mM glycine
(EM Science), 0.1% SDS) until the bromophenol blue ran
out of the bottom of the gel,.
The 2D gels were then stained with a fluorescent phos-
phoprotein stain, ProQ Diamond, according to the man-
ufacturer's instructions (Invitrogen-Molecular Probes,
Burlington, Ontario, Canada). Fluorescence was detected
with UV light using a ChemiImager 4000 imaging system
(Alpha Innotech Corporation, San Leandro CA USA). The
gels were then stained for total protein by washing in 50%
ethanol (EM Science) and 3% phosphoric acid with shak-
ing overnight, rinsing three times for 30 min in water,
equilibrating in 16% ammonium sulfate (EM Science),
25% methanol (EM Science), 5% phosphoric acid for 1
hour, and subsequently staining by adding Coomassie
brilliant blue G250 (Sigma-Aldrich) to 0.01% and shak-
ing for 4 days. Images were obtained by scanning the gels
with a Li-Cor Odyssey scanner (Li-Cor, Lincoln NE USA)
at 700 nm. Protein spot density was analyzed using Li-Cor
Odyssey Ver. 2.0.5 software (Li-Cor). Gel images were
analyzed using Adobe PhotoShop Ver. 5.0 (Adobe Sys-
tems Inc., San Jose CA USA).
Mass spectrometry analysis
Protein spots of interest were excised from the 2D gels and
the proteins within were reduced, alkylated, and digested
with trypsin according to an in-gel digestion protocol
[100] with a few modifications. The gel pieces were
destained in 50% methanol/5% acetic acid (ACP Chemi-
cals Inc.), dehydrated with acetonitrile (EM Science),
dried, reduced with 50 mM DTT in 100 mM ammonium
bicarbonate at 56°C for 30 min, alkylated with 100 mM
iodoacetamide in 100 mM ammonium bicarbonate at
45°C for 30 min, dehydrated with acetonitrile, hydrated
with 100 mM ammonium bicarbonate, dehydrated with
acetonitrile, dried, and digested with 20 ng/μl of sequenc-
ing grade modified trypsin (Promega Corp., Madison WI
USA) in 50 mM ammonium bicarbonate at 37°C over-
night. The resulting peptides were extracted out of the gel
pieces by successive incubation in 50 mM ammonium
bicarbonate for 1 hour at 37°C and twice in 0.1% formic
acid (ACP Chemicals Inc.) for 30 min at 37°C. The pep-
tides were desalted using ZipTip pipette tips containing
C18 reversed-phase media (Millipore Corp., Bedford, MA
USA) by washing with 0.1% formic acid and eluting with
75% acetonitrile/0.1% formic acid. Peptides were either
analyzed by MALDI-TOF MS as follows or by ESI-QqTOF
or MALDI-TOF-TOF MS analysis as described in the
iTRAQ section. Peptide samples were applied to the target
plate with an equal volume of matrix solution (1% α-
cyano-4-hydroxycynnamic acid (Sigma-Aldrich) in 50%
acetonitrile/0.3% formic acid) and allowed to dry. Adren-
ocorticotropic hormone fragment 1–17 (FW 2093.4),
bradykinin fragment 2–9 (FW 904.0) and angiotensin 1
(FW 1296.5) (Sigma-Aldrich) were used as external cali-
brants.
Spectra were obtained using a Voyager-DE STR Biospec-
trometry Workstation MALDI-TOF mass spectrometer (PE
Applied Biosystems, Foster City, CA USA) operating in
positive reflector mode with delayed extraction. Data were
manipulated using the Voyager Version 5.1 software with
Data Explorer (PE Applied Biosystems). The sample spec-
tra were further internally calibrated using autolytic
trypsin peptide peaks. The masses of the tryptic peptides
were used to search a local protein database using MAS-
COT Peptide Mass Fingerprint software (Matrix Science
Inc., Boston MA USA) using the following settings: all
entries, 1 missed cleavage, cysteines modified by carbami-
domethylation, oxidized methionines, deamidation of
asparagine and glutamine, peptide mass tolerance of ± 50
ppm. If the tryptic peptides were analyzed by ESI-QqTOF
generating MS/MS spectra, manual de novo sequencing
was performed viewing the spectra on AnalystQS Ver. 1.1
software (Applied Biosystems, Foster City, CA USA) orBMC Developmental Biology 2007, 7:94 http://www.biomedcentral.com/1471-213X/7/94
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automatically using PEAKS Studio Ver.3.0 software (Bio-
informatics Solutions Inc., Waterloo ON Canada) as
explained in the data analyses section for iTRAQ. The
group of peptide spectra that were obtained from the RLK
I spot were analyzed using SPIDER software [101].
Immunoblotting
Protein samples from the total extract and subcellular
fractions were analyzed for lamin B1+B2 and for cyto-
chrome c. Protein samples of the 48 hour control and
treatment microsomal fraction were analyzed for cytoker-
atin in duplicate. Thirty μg of protein per sample was
boiled for 3 min in 25 μl of 60 mM Tris-base pH 6.8, 2%
SDS, 10% glycerol, 100 mM DTT, 0.03% bromophenol
blue and loaded onto a 12% SDS-PAGE (see '2D gel elec-
trophoresis' above for gel and buffer compositions). Pro-
teins were then electrophoretically transferred onto a
nitrocellulose membrane (Bio-Rad). Membranes were
blocked with 5% nonfat milk in 140 mM NaCl/20 mM
Tris-base pH 7.6 (TBS), for 1 hour, then probed with a
pan-cytokeratin rabbit polyclonal IgG antibody (H-240;
Santa Cruz Biotechnology Inc., Santa Cruz CA USA)
diluted at 1/500 or an anti-lamin B1+B2 mouse mono-
clonal IgG1 antibody (ab4825; Cedarlane, Hornby ON
Canada) diluted at 1/50 or anti-cytochrome c rabbit poly-
clonal antibody (H-104; Santa Cruz Biotechnology Inc.)
diluted at 1/200 in 5% nonfat milk/TBS and 0.1% Tween
(TBST) with gentle agitation for 1 hour at room tempera-
ture. The blots were washed with TBST for 1 hour. The
membranes were then incubated with secondary anti-
body, IRDye-800 conjugated anti-rabbit IgG or IRDye-
800 conjugated anti-mouse IgG (Rockland Inc., Gilberts-
ville PA USA) diluted at 1/2000 in 5% nonfat milk/TBST
for 1 hour at room temperature. The blots were washed
with TBST for 1 hour. The prepared blots were scanned by
a Li-Cor Odyssey scanner at 800 nm.
Isolation of RNA, generation of cDNA, degenerate-primer 
PCR and 5'-/3'-RACE
RNA was isolated and cDNA generated from premetamor-
phic tadpole tail fin tissue as described in Veldhoen et al
[9]. The resulting cDNA was used for PCR using degener-
ate primers: forward: 5'-GAA/G GCA/C GCC AAT/C ACT/
C GAA/G CT-3' and reverse: 5'-AC C/TTG T/AAG C/TTC
CTC T/CTC G/ATG-3' (32 fold degeneracy each) with an
initial 94°C for 10 min then 40 cycles at 94°C for 30 sec,
52°C for 30 sec, and 72°C for 30 sec, followed by 10 min
at 72°C. This generated a single product at 380 bp. The
PCR product was cloned using the TOPO TA Cloning Kit
System with pCR2.1 TOPO vector and TOP10 cells (Invit-
rogen) as described previously [102]. The insert was then
sequenced in both directions using the TOPO kit M13 for-
ward and reverse primers at the University of Victoria
sequencing facility. Based on this sequence two gene spe-
cific primers (GSP) were designed: GSP1 for 5'-RACE: 5'-
TGTCTCCACCGCTAACACCAACGCCAAC-3' and GSP2
for 3'-RACE: 5'-GTTGGCGTTGGTGTTAGCGGTGGA-
GACA-3'. RACE-ready cDNA libraries were made from
total RNA using the Smart RACE cDNA kit (BD Bio-
sciences, Burlington ON Canada). The RACE reactions
used the universal primers supplied with the kit paired
with the GSP1 and GSP2. Touchdown PCR was performed
on the RACE-ready libraries: 94°C for 2 min; five cycles at
94°C for 30 sec, and 72°C for 3 min; five cycles at 94°C
for 30 sec, 70°C for 30 sec, and 72°C for 3 min; and 25
cycles at 94°C for 30 sec, 68°C for 30 sec, and 72°C for 3
min. The 5'-RACE produced a single product of ~600 bp
and the 3' RACE produced three products between ~1400
and ~1500 bp. The PCR products were cloned as above
and the longest clones from each RACE reaction were
sequenced as above, giving two overlapping sequences
that encoded the complete open reading frame. The
sequence reported in this manuscript is accessible in Gen-
Bank [GenBank: EF156435].
Quantitation of gene expression
The expression of RLK I gene transcript was quantified in
tails of individual animals (n = 4 for all treatments and/or
time points). Tail tissue treatment, RNA isolation and
cDNA generation was performed as indicated above and
expression data were collected using a real-time quantita-
tive PCR assay on a MX4000 system (Stratagene, La Jolla,
CA, USA) as described previously [103] using the follow-
ing primers for RLK I: 5'-GTTGGCGTTGGTGTTAGCGG-3'
and 5'-GGCACTGCTTCTTGCAACTTG-3'. The QPCR
product from the keratin transcript was analyzed on a gel
and sequenced ensuring that only this specific keratin
transcript was being analyzed. The invariant L8 ribosomal
protein transcript was used as a normalizer [103].
Differential expression analysis using iTRAQ
Peptide preparation, iTRAQ labeling, two-dimensional liquid 
chromatography separation and MS analysis
Proteins from tadpole tail fin tissue were extracted by
homogenization in 6 M urea, 0.2% SDS, 20 mM HEPES
pH 7.5 (3 ml/g tissue). The homogenate was centrifuged
at 12,000 × g for 15 min at 4°C. The supernatant was
adjusted to 4 M urea, 0.05% SDS, 2 mM MgCl2 and 20
mM HEPES pH 8.0, and DNA was digested with 10 U/ml
of benzonase for 30 min at 8°C. The iTRAQ reagents were
used according to the manufacturer's protocol with minor
modifications as follows (Applied Biosystems).
Two independent control and two independent treatment
protein samples were quantified using the bicinchoninic
acid assay (BCA) (Sigma-Aldrich, St Louis, MO USA). One
hundred μg of each sample (~55 μl) was precipitated in 1
ml cold acetone, overnight at -20°C. Proteins were then
reduced in 3.3 mM tris-(2-carboxyethyl) phosphine,
alkylated with 6.7 mM methyl methane thiosulfonateBMC Developmental Biology 2007, 7:94 http://www.biomedcentral.com/1471-213X/7/94
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(MMTS) and digested overnight with 10 μg of sequencing
grade modified trypsin (Promega, Madison, WI USA) at
37°C. The resulting peptides from the two control sam-
ples were labeled with iTRAQ reagents 114 and 116, while
peptides from the two T3 treatment samples were labeled
with iTRAQ reagents 115 and 117.
The labeled peptide samples were then pooled, adjusted
to pH 2.5–3.0 with concentrated phosphoric acid (ACP
Chemicals Inc., Montreal, QC Canada), and separated by
strong cation-exchange chromatography (SCX) using a
PolySULFOETHYL A SCX column (100 × 4.6 mm, 5μm,
300Å - PolyLC Inc., Columbia, MD USA) on the VISION
Workstation (Applied Biosystems, Foster City, CA USA).
Mobile phases used were: Buffer A: 10 mM monobasic
potassium phosphate (Sigma-Aldrich, St Louis, MO,
USA), 25% acetonitrile (ACN) (EMD Chemicals, Gibbs-
town, NJ, USA), pH 2.7 and Buffer B: same as A with the
addition of 0.5 M potassium chloride (Sigma-Aldrich St
Louis, MO, USA). Fractions of 500 μL were collected over
an 80 minute gradient: 0–30 min, 5% to 35% Buffer B;
30–80 min, 35% to 100% Buffer B. Sixteen SCX fractions
were reduced to 150 μL using a SpeedVac and subjected to
reverse-phase chromatography using an integrated system
consisting of a Famos autosampler, Switchos switching
pump, UltiMate micro pump and a Probot microfraction
collector (LC Packings, Amsterdam, Netherlands). The
SCX fractions were first desalted on a C18 PepMap guard
column (300 μm i.d. x 5 mm 5 μm, 100Å, LC Packings,
Amsterdam) at 50 μl/minute flow rate for 15 min. Pep-
tides were separated over a manually packed 75 μm × 15
cm C18 column (Magic C18Aq, 5μm, 100Å, Michrom
Bioresources Inc., Auburn CA, USA) using a 85 min gradi-
ent of 5%-75% ACN in 0.1% formic acid flowing at 250
nL/min.
The eluant was either sprayed directly into an Applied Bio-
systems QSTAR Pulsar i (Applied Biosystems/MDS SCIEX
Concord, ON Canada) (ESI-QqTOF) mass spectrometer
or spotted onto a MALDI target plate by the Probot for LC-
MALDI analysis. The QSTAR operating software Analyst
QS v1.1 employed an information dependent acquisition
(IDA) method for optimized MSMS spectra acquisition
over a 6 sec cycle which was repeated over the duration of
the gradient. The MS-TOF survey scan lasted for 1 sec over
a range of 400–1200 m/z targeting precursor ions of
charge state 2–5+ that exceeded a threshold of 20 counts.
Former target ions within 100 ppm were excluded for the
next 180 sec. The two most intense ions that met the IDA
criteria were gated and fragmented with optimized colli-
sion energy. Each product ion scan lasted for 2.5 sec over
a range of 100–1500 m/z. 'Enhance-all' was turned on for
the product ion scans. LC-MALDI data was acquired on an
Applied Biosystems 4800 MALDI TOF/TOF Analyzer
(Applied Biosystems/MDS Sciex Foster City, CA USA).
Sample spots were overlaid with 3 mg/mL α-cyano-4-
hydroxycinnamic acid (CHCA) (Sigma-Aldrich, St Louis,
MO USA) matrix in 50% ACN and 0.1% TFA. MS data was
automatically acquired over a mass range of 800–4000 Da
using fixed laser intensity for 500 shots with a uniformly
random spot search pattern. In each spot, the 30 strongest
peaks by MS (determined by cluster area) were selected for
MS/MS using a job-wide interpretation method which
excludes ions with a signal-to-noise of less than 60 and fil-
ters identical peaks detected in multiple spots. A 1 KV pos-
itive MS/MS operating mode was used with the relative
precursor mass window set at 150 and collision induced
dissociation turned on. MALDI-TOF-TOF data analysis
was performed using GPS Explorer Ver. 3.0 (Applied Bio-
systems) software using the MASCOT (Matrix Science)
search engine for protein database searching.
iTRAQ data analysis
All of the MS data in ProQUANT (Applied Biosystems)
resulting from the ESI-QqTOF analysis was transferred to
Excel (Microsoft Corporation, Redmond WA) where the
data was filtered to reveal only those MS spectra where a
change of 1.5 fold or higher was observed between the
treatment and the control for both duplicates. An addi-
tional requirement was that the ratio of the iTRAQ tags
between the two controls had to be between 0.67 and 1.5.
The resulting MS spectra were then manually inspected in
AnalystQS 1.1 (Applied Biosystems) software to ensure
good quality of the iTRAQ tags and fragmentation infor-
mation.
High quality spectra where then used for de novo peptide
sequencing. Peptide sequence was obtained by either
manually interpreting spectra and/or through the use of
PEAKS Studio Ver.3.0 (Bioinformatics Solutions Inc.)
software capable of auto de novo sequencing. The parame-
ters were set as follows: parent mass error tolerance of 0.1
Da, fragment mass error tolerance of 0.1 Da, enzyme used
was trypsin, fixed posttranslational modifications (PTMs)
were MMTS on cysteines, iTRAQ tags on N-terminal and
lysine, and variable PTMs were iTRAQ tag on tyrosine and
oxidation of methionine histidine and tryptophan. All of
the results were manually inspected to ensure correctness.
The resulting peptide sequences were then queried against
the Entrez Protein (NCBInr) database (Oct. 15, 2006)
using BLASTp [21] to allow for short, nearly exact
matches: no compositional adjustments, a low complex-
ity filter, expect threshold of 20000, word size of 2, using
matrix PAM 30, with gap costs of 9 for existence, and 1 for
extension, searching all metazoan sequences.
Statistical analyses
Statistical analyses were performed using SPSS Ver. 12.0.
(Chicago IL USA). For the 48 hour 2D gel analysis data P-
values were determined using a one-way ANOVA with aBMC Developmental Biology 2007, 7:94 http://www.biomedcentral.com/1471-213X/7/94
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test for homogeneity of variance and a Shapiro-Wilk test
of normality. For the QPCR analyses P-values were deter-
mined using the Mann-Whitney U non-parametric two-
tailed test.
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Additional file 1
Additional changes identified in 2D analyses of the microsomal fraction. 
2D gel regions of the microsomal fraction showing the increase of a pro-
tein spot at ~30 kDa and pI ~5 due to T3 treatment at 48 h. Relative 
molecular weights of protein standards are indicated in kDa. Spot density 
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